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ABSTRACT 
 
Characterization of a Broad Host Range Tailocin from Burkholderia. (August 2012) 
Iris Duarte, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Carlos F. Gonzalez 
 
 Members of the Burkholderia cepacia complex (Bcc) are plant and human 
opportunistic pathogens.  Essentially all Bcc isolates demonstrate in vitro broad-
spectrum antibiotic resistance.  In fact, many clinical isolates are resistant to all currently 
available antibiotics, rendering therapy ineffective.  There is a substantial need to 
develop new antimicrobial therapies.  The potential use of phage-tail-like high molecular 
weight bacteriocins, or "tailocins", as alternative anti-bacterial agents against Bcc was 
investigated.  A tailocin, designated Bcep0425, produced by B.cenocepacia strain 
BC0425 was determined to have broad host range activity against members of the Bcc.  
Targeted mutagenesis of genes involved in the biosynthesis of the bacterial 
lipopolysaccharide (LPS) was conducted to determine the receptor site and it was 
determined that L-rhamnose and α-glucose associated with the LPS core were the 
receptors. Genetic analysis and targeted mutagenesis of the tailocin encoding genes was 
conducted in the host strain, B. cenocepacia BC0425, to determine the genetic 
organization of the tailocin Bcep0425 gene cluster and to confirm gene functions.  We 
report for the first time genes involved in replication and integration that are associated 
with a pyocin/tailocin gene cluster.  Additionally, a new class (IV) of holin was 
 iv
identified as part of the lysis cassette.  Genetic analysis of the tailocin encoding genes 
revealed a high degree of similarity to defective phages identified in sequenced 
Burkholderia genomes.  Two novel transcriptional regulators, bctN and bctR, along with 
recA were found to be involved in the induction of Bcep0425.  Numerous studies have 
focused on the characterization of pyocins from Pseudomonas, but there have been no 
molecular investigations of tailocins from Burkholderia.  This constitutes the first 
molecular characterization of a phage tail-like bacteriocin from Burkholderia.   
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CHAPTER I 
GENERAL INTRODUCTION 
 
 The Burkholderia cepacia complex (Bcc) consists of at least 17 phenotypically 
similar, but genotypically distinct species of non-fermenting, Gram-negative bacteria 
that are found in a diverse set of niches (21, 66, 109). These species have a high degree 
of 16S rDNA gene (98–100%) and recA (94–95 %) sequence similarity, and moderate 
levels of DNA–DNA hybridization (30–50%) (20).  Members of the Bcc are 
opportunistic pathogens, capable of causing disease in plants, animals and particularly 
causing life-threatening respiratory infections in persons with cystic fibrosis (9, 34, 63).  
Strains isolated from infected cystic fibrosis (29) patients indicate that the distribution of 
species is quite disproportionate, with B. cenocepacia and B. multivorans accounting for 
85–90% of infection in this patient population (64, 65). 
 Infection by members of the Bcc in CF patients, results in acute pulmonary 
disease and sepsis (referred to as “cepacia syndrome”) or chronic respiratory tract 
infection associated with an accelerated decline in lung function.  The resultant altered 
epithelial surface liquid, in some way, predisposes the respiratory tract of affected 
persons to bacterial infections (25). Since the mid-1980s, the rates of Bcc infections have 
dramatically increased.  In some centers, up to 45% of patients have become infected.  
Some of the reasons for this increase are the increased use of antibiotics, social and  
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behavioral changes that have allowed for close contact between patients (79), and the 
more accurate identification of Bcc organisms (21).  Most clinically relevant strains of 
the Bcc have demonstrated in vitro broad-spectrum antibiotic resistance.  Even with 
combined antibiotic therapy, clearance of the microorganisms is not observed.  There is 
a substantial need to develop new strategies for antimicrobial therapy against these 
pathogens.  The use of bacteriophage or high molecular weight (HMW) bacteriocins, as 
potential anti-bacterial agents against the Bcc is an alternative currently being 
investigated in our laboratory.   
 Bacteriocins are bacterial products with specific bactericidal activity, generally 
towards species closely related to the producer strain (27).   The first bacteriocin was 
described in Pseudomonas aeruginosa by Francois Jacob (49).  Jacob showed that a 
mutagenic agent (i.e. UV irradiation) produced an inducible compound, released by 
bacterial lysis, specifically adsorbing on the cell surface of susceptible bacteria and 
provoking their death.  The term pyocin has been used to describe the bacteriocins 
produced by strains of Pseudomonas.   Pyocins produced by P. aeruginosa are 
chromosomally encoded and their synthesis is induced by the SOS response (75).  Cell 
lysis, a process similar to phage-mediated lysis, then releases the particles into the 
surroundings.  The two types of bacteriocins released into the surroundings are either 
high-molecular weight (HMW) or low-molecular weight (LMW) bacteriocins.    
 HMW bacteriocins are thermolabile, trypsin resistant, and sedimentable by 
ultracentrifugation and they have been identified in many families, such as 
Enterobacteriaceae, Vibrionaceae, and Pseudomonadaceae (14, 19, 52).  LMW 
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bacteriocins are soluble and protease sensitive (78).   Electron microscopy has revealed 
that HMW bacteriocins have a structure resembling that of many bacteriophage tails.  
The most thoroughly studied phage tail-like bacteriocins are the F-type and R-type 
pyocins produced by P. aeruginosa.  R-type pyocins have a contractile sheath 
resembling the T-even coliphage tail whereas the F-type pyocins have sheathless, 
flexible rod-like structures resembling the lambda phage tail (81). 
  R-type pyocins are rod-like structures that correspond to a double hollow 
cylinder, which consists of a sheath and core (47, 105, 125).  The sheath is constituted 
by protein subunits arranged in helix symmetry, capable of contraction.  The core is the 
same length and located inside the sheath.  Pyocins also contain a baseplate at the distal 
end and have six tail fibers attached.  These tail fibers are responsible for specificity.  
Pyocins bind to a cell surface receptor via their tail fibers, which is then followed by 
sheath contraction and insertion of their core through the cell envelope.  Since pyocin 
genes are chromosomally located and their gene organization clearly demonstrates they 
possess an ancestral origin common with bacteriophages, it has been suggested that 
pyocins have evolutionarily specialized as phage tails, rather than being just simple 
defective phages (81).              
 Morphologically and genetically, R-type pyocins resemble tails of Myoviridae 
bacteriophages, but have no head structure and thus no nucleic acid (47, 53, 54, 98).  
Pyocins bind to targeted bacterial surface molecules and insert a core or needle that 
dissipates the bacterial membrane potential (108).  This bactericidal event can result 
from the binding of a single pyocin particle.   Their mechanism of action, high 
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bactericidal potency, and focused spectrum suggest that R-type pyocins can be 
developed as antibacterial agents (96). The term tailocin will be used to refer to R-type 
pyocins produced by Burkholderia species.  Our laboratory has isolated a tailocin from 
B. cenocepacia strain BC0425, designated Bcep0425.  Tailocin Bcep0425 can only be 
induced upon exposure of BC0425 to UV irradiation.  Other mutagen agents, such as 
mitomycin C, are not able to trigger induction of Bcep0425.  The lysis of BC0425 upon 
induction is associated with the production of tailocin Bcep0425.  Tailocin Bcep0425 
measures 140 nm in length and similar to other reported HMW bacteriocins, is resistant 
to proteases and is thermolabile (78).   
 Studies in the early 1970s showed R-type pyocins to be effective as antimicrobial 
agents of peritonitis in mice (37, 77, 95, 119).  Unfortunately, due to the effectiveness of 
antibiotics at the time, there was little interest in pursuing pyocins or bacteriophages as 
anti-bacterial agents.  With the emergence of multi-drug resistant bacteria, this avenue is 
now being reexamined.  Currently R-type pyocins are being re-engineered to generate 
novel bactericidal protein complexes (95, 119).  Pyocins that were once only effective 
against Pseudomonas species have now been modified to extend their adsorption range, 
with the alteration of the C-terminus of their tail fibers, and are effective against 
Escherichia coli and Yersinia pestis strains (95, 119).  Although the bactericidal spectra 
of pyocins can now be altered, it still remains limited to specific species and even strains 
(119).  Tailocin Bcep0425 is unique because it exhibits broad host range activity, not 
only against members of the Bcc, but other genera as well.  The characterization of 
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Bcep0425 is vital to understanding its specificity and will give insight into the 
evolutionary relationship between pyocins/tailocins and bacteriophage.    
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CHAPTER II 
ORGANIZATION OF THE GENE CLUSTER ENCODING FOR TAILOCIN 
BCEP0425  
 
INTRODUCTION 
 
Pyocins are produced by more than 90% of P. aeruginosa strains (78).  Each 
strain may produce several pyocins, which are chromosomally encoded.  The R2-type 
pyocin genes are located on the P. aeruginosa PAO1 chromosome between the trpE and 
trpGCD genes (101).  The locus is approximately 13 kb and contains 16 open reading 
frames (ORFs) (101).  These ORFs have been assigned to five gene clusters: 1) genes 
regulating gene expression; 2) genes of unknown function; 3) genes related to lysis; 4) 
R-type pyocin structural genes; and 5) F-type pyocin structural genes (81).  Regulatory 
and lysis genes are generally shared by both the R-type and F-type pyocins and are 
transcribed as two independent transcriptional units (75).  Function was assigned to 
pyocin genes based on significant sequence similarity to bacteriophages P2, CTX, and 
other P2-like phages (81).  This sequence similarity, along with the identification of lysis 
cassettes, has led to the notion that pyocins were derived from a common ancestral 
origin, bacteriophage P2, and suggests that pyocins are not simple defective phages, but 
are phage tails that have been evolutionarily specialized as bacteriocin (81).      
R-type pyocins resemble inflexible and contractile tails of bacteriophages (52).  
They are similar to each other in their structural and serological properties, but different 
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in receptor specificity.  The tail fiber protein, which is responsible for binding to the 
receptor of a sensitive bacterial strain, has been proposed to account for the observed 
difference in specificity (82).  R-type pyocins can be viewed as non-infectious particles, 
consisting of only the tail apparatus that have been adapted by the host as defensive 
antibacterial agents (95, 119).  Since the producing bacterium is lysed in the process of 
releasing the pyocins, this defense system is often viewed as altruistic.   
Pyocin production is induced by the SOS response, which yields about 100 to 
200 particles per cell (75).  The cells then lyse, by a process similar to phage-mediated 
lysis, to release the accumulated pyocin particles to the environment.  A physical barrier 
consisting of the host cytoplasmic membrane, cell wall, and, in the case of Gram-
negative bacteria, the outer membrane must be overcome.  Pyocins are found to encode a 
lysis gene cassette similar to those used by lytic bacteriophage (81) .   
Bacteriophages are lytic, except for filamentous phages, which extrude from their 
host.  There are at least two general strategies for host lysis (120).  Single-stranded DNA 
and single-stranded RNA phages of some Gram-negative hosts, accomplish lysis with a 
single lysis gene that does not encode muralytic enzyme activity.  In this system, the 
lysis protein is an inhibitor of murein synthesis (8).  Double-stranded DNA phages of 
eubacteria resort to active degradation of the peptidoglycan with a muralytic enzyme or 
endolysin to achieve lysis (122, 123).  One of the most studied lysis systems is that of 
bacteriophage λ.  The λ lysis cassette encodes four genes: the holin, endolysin, Rz, and 
Rz1 (116).  The holin and endolysin are two proteins that are essential for bacteriophage 
host lysis.  Endolysin is a generic term describing an enzyme that degrades the bacterial 
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peptidoglycan cell wall and that accumulate in the cytosol after induction of the lytic 
cycle (122).  Holins are small membrane proteins that control lysis by accumulating in 
the membrane and causing lesions in the cytoplasmic membrane, until at a specific time 
that is “programmed” into the holin gene, the membrane suddenly becomes 
permeabilized and the endolysin escapes to the periplasm (117).  A third class of 
proteins, the spanins (Rz and Rz1), are involved in disrupting the outer membrane (OM).  
Rz and Rz1 are an inner membrane protein and an OM lipoprotein, respectively, which 
span the entire periplasm by C-terminal interactions of their soluble domains (10). 
In the study communicated in this chapter, I report on the nucleotide sequence 
analysis of tailocin Bcep0425 to determine the structural and genetic relationship 
between tailocin Bcep0425 and known pyocins or bacteriophages.  This study also 
reports on the assignment of Bcep0425 gene functions, the location of the tailocin 
Bcep0425 gene cluster within the BC0425 host genome, the confirmed role of the holin, 
antiholin and endolysin in host lysis, and provides evidence that tailocin Bcep0425 is a 
defective phage.  
 
EXPERIMENTAL PROCEDURES 
 
Bacterial strains, plasmids, and growth conditions.  The bacterial strains and 
plasmids used in this chapter are listed in Table 2.1.  The complex medium TN broth 
(TNB) was used for routine maintenance of cultures (42).  Solid medium, TNA, was 
identical except it lacked KNO3 and was supplemented with 20 g/L agar.  For soft agar 
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overlays, TN medium was amended with 7.5 g agar/L (TNSA). Luria-Bertani (LB) 
medium was used in mating experiments (11).  For counter-selection, co-integrants were 
grown in Yeast-Tryptone (YT) broth, which consisted of 10 g tryptone and 10 g of yeast 
per liter of water.  Sucrose was added to YT broth at a final concentration of 15% 
(wt/vol) and supplemented with 20 g/L agar (YTSA).  B. cenocepacia and Escherichia 
coli strains were grown at 37°C.  Antibiotics were added to the media at the following 
concentrations: 600 µg/ml kanamycin (Km) and 20 µg/ml tetracycline (Tc) for B. 
cenocepacia; 30 µg/ml Km for E. coli.   
DNA manipulations.  Genomic DNA was extracted using a DNeasy kit 
(Qiagen), small-scale plasmid preparation was accomplished using the Miniprep kit 
(Qiagen), and gel extraction and PCR product purification were conducted using 
Quiaquick gel extraction kit and Quiaquick PCR purification kit, respectively (Qiagen).  
All restriction endonucleases, Taq DNA polymerase and T4 DNA ligase were purchased 
from New England Biolabs and were used according to manufacturer protocols.  
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT).   
DNA sequence analyses were conducted by the Institute of Developmental and 
Molecular Biology, Gene Technologies Laboratory at Texas A&M University.  
SDS-PAGE gel and LC-MS/MS analysis. Tailocin preparation was analyzed 
for its protein components.  The major proteins were separated using SDS-PAGE gel 
electrophoresis along with a Precision Plus protein standard (Bio-Rad) and stained with 
Coomassie brilliant blue R250 (60).  Protein subunits were dissociated at 95°C for 5 
min, in 20 µl of 50 mM Tris-HCl buffer (pH 7.5) containing 0.01 g of SDS, 1.54 mg of  
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Table 2.1.  Bacterial strains and plasmids used in Chapter II 
Strain  Relevant Characteristics Reference or Source 
Burkholderia cenocepacia   
BC0425 Producer of tailocin Bcep0425 J. LiPuma 
J2315 ET12 epidemic lineage Laboratory stock 
PC184 Midwest epidemic lineage J. LiPuma 
BC0425∆ holin BC0425, deleted holin gene This study 
BC0425∆ antiholin BC0425, deleted antiholin gene This study 
BC0425∆ endolysin BC0425, deleted endolysin gene This study 
Escherichia coli   
DH5αMCR Cloning strain, F- endA1 hsdR17 
(rk-, mk+) supE44 thi-1 λ- recA1 
gyrA96 relA1 deoR ∆(lacZYA-
argF)- U169 Φ80dlacZ∆M15 
Invitrogen 
Plasmids    
pRK2013 Tra+ Mob+ ColE1 replicon, Kmr Laboratory stock (30)  
pMo130 Suicide vector for allelic 
exchange in Burkholderia; ColE1 
ori, RK2 oriT, xylE, sacB, KmR 
M. Voskuil (41) 
pMo168 Replicative vector for 
Burkholderia; oripBBR1, mob+, 
xylE, KmR 
M. Voskuil (41) 
pMo130:: antiholin pM0130 with antiholin upstream 
and downstream fragments 
This study 
pmo130:: endolysin pM0130 with endolysin upstream 
and downstream fragments 
This study 
pMo130:: holin pM0130 with holin upstream and 
downstream fragments 
This study 
pMo168:: anti-comp antiholin gene cloned into 
pMo168 
This study 
pMo168:: endo-comp endolysin gene cloned into 
pMo168 
This study 
pMo168:: holin-comp holin gene cloned into pMo168 This study 
KmR = resistance to kanamycin.  + and -  = positive and negative for phenotype, 
respectively.   
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dithiothreitol, and 0.1 mg of bromophenol blue per ml.  To identify the amino acid 
composition of the 43 kDa and 17 kDa proteins, bands were excised from a 10-20 % 
Tris-HCl gel, and the 100 kDa and 30 kDa bands were excised from a 7.5% gel Tris-HCl 
gel.  The proteins were subjected to Liquid Chromatography-Mass Spectometry 
(MS)/MS analysis on the Q-TOF Premier Mass Spectrometer.  Protein LynX global 
Server and Mascot search engines were used to search the SwissProt 
(http://ca.expasy.org/sprot) and NCBI databases (http://ncbi.nlm.nih.gov/Blast) (1, 13). 
Annotation of Bcep0425 genes.  To understand the genetic organization of 
Bcep0425, BC0425 genomic DNA was isolated using modifications of the CTAB 
method (5).  BC0425 DNA was sequenced using 454 genome sequencing technology 
(Duke University, Institute for Genome Sciences & Policy). Sequence information was 
assembled into contigs using the Newbler sequence assembly program (Roche, USA).  
Genemark (http://exon.biology.gatech.edu/gmhmm2_prok.cgi) was used to predict all 
possible open reading frames.  To annotate contig 77, which contains the Bcep0425 
genes, Genemark (http://exon.biology.gatech.edu/gmhmm2_prok.cgi) was first used to 
identify all possible ORFs (12).  The Artemis Comparison Tool (Sanger Centre) was 
then used to identify the most likely start codon for each ORF, by searching for the 
presence of a potential ribosomal binding site (RBS) (18).  Each identified ORF was 
then compared to the NCBI protein database using Blastp (http://ncbi.nlm.nih.gov/Blast) 
to assign putative functions (1).  InterProScan 
(http://www.ebi.ac.uk/Tools/webservices/services/interproscan), LipoP 
(http://www.cbs.dtu.dk/services/LipoP/), and TMHMM 
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(http://www.cbs.dtu.dk/services/TMHMM/) were used to identify conserved domains, 
lipoprotein processing signals, and transmembrane domains (TMDs), respectively.  
Genome maps were drawn utilizing the programs DNA Master 
(http://cobamide2.bio.pitt.edu/computer.htm).   
Determining the insertion site of Bcep0425.  A draft genomic sequence of B. 
cenocepacia strain BC0425 was used for this study.  Primer walking was used to 
determine the insertion site location of Bcep0425 in the BC0425 host chromosome.  
Primer sets C77L (contig77-left and C77L-F2) and C77R (contig77-right and  C77R-R1) 
(Table 2.2) were designed based on the sequence data of B. cenocepacia strain J2315 
produced by the Pathogen Sequencing Group at the Sanger Institute, Hinxton, 
Cambridge and can be obtained from http://www.sanger.ac.uk/Projects/B.cenocepacia/.  
Primers were designed to extend out from either side of contig 77.  Sequencing was 
conducted by the Institute of Developmental and Molecular Biology, Gene Technologies 
Laboratory at Texas A&M University.  Using the sequence obtained, a search of the 
remaining contigs of BC0425 was conducted and contigs flanking contig77 were 
identified.  Once both contigs were identified, the sequences were annotated using the 
methods described above.   
Plasmid construction for allelic exchange.  Deletion of the antiholin, endolysin, 
and holin genes of BC0425 were constructed using the system developed by Hamad et 
al. (41).  PCR primers for regions flanking the antiholin were designed based on the 
annotated sequence of BC0425.  To construct plasmid pMo130:: antiholin used to delete 
the antiholin from BC0425, a 1.0 kb fragment upstream of the antiholin gene was 
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amplified with primers anti-up-F and anti-up-R (Table 2.2) and cloned into multiple 
cloning site (MCS) 1 of plasmid pMo130, digested with NheI and BglII, to obtain 
plasmid pMo130:: antiholin-up.  The 1.0 kb fragment downstream of the antiholin gene 
was amplified using primers anti-down-F and anti-down-R (Table 2.2).  The PCR 
product was cloned into pMo130:: anti-up, digested with BglII and HindIII, to obtain 
pMo130:: antiholin.  
PCR primers for regions flanking the endolysin were designed based on the 
annotated sequence of BC0425.  To construct plasmid pMo130::endolysin used to 
construct a deletion of the endolysin gene, a 1.0 kb fragment upstream of the endolysin 
was amplified with primers endo-up-F and endo-up-R (Table 2.2) and cloned into MCS1 
of plasmid pMo130, digested with NheI and BglII, to obtain plasmid pMo130:: 
endolysin-up.  The 1.0 kb fragment downstream of the endolysin was amplified using 
primers endo-down-F and endo-down-R (Table 2.2).  The PCR product was cloned into 
pMo130:: endolysin-up, digested with BglII and HindIII, to obtain pMo130:: endolysin.   
PCR primers for regions flanking the holin were designed based on the annotated 
sequence of BC0425.  To construct plasmid pMo130:: holin used to delete the holin gene 
from BC0425, a 1.0 kb fragment upstream of the holin was amplified with primers 
holin-up-F and holin-up-R (Table 2.2) and cloned  into MCS1 of plasmid pMo130, 
digested with NheI and BglII, to obtain plasmid pMo130:: holin.   The 1.0 kb fragment 
downstream of the holin was amplified using primers holin-down-F and holin-down-R 
(Table 2.2).  The PCR product was cloned into pMo130:: holin-up, digested with BglII 
and HindIII, to obtain pMo130:: holin.   
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Table 2.2.  Primers used in Chapter II 
Primer Relevant Characteristics Reference 
contig77-left 5'-GCTGGGAGACGATGGAAAT-3' This study 
C77L-F2 5'-TCTTCAGCAGCGTGTCGAAG-3' This study 
contig77-right 5'-CTTGTGCAACCTTGGTTTTG-3' This study 
C77R-R1 5'-AGCGCTTGTATTCGTCGATC-3' This study 
anti-up-F 5'-CTGGCTAGCGTCGAGCCGCACCTGCTGTT-3' This study 
anti-up-R 5'-CTCAGATCTGAGCGAATGACGATGAAAACC-3' This study 
anti-down-F 5'-CTCAGATCTCGGGAACGCCACGTCACCCT-3' This study 
anti-down-R 5'-GACAAGCTTCGCAAAATCGCCGTGCGGCAA-3' This study 
endo-up-F 5'-GAGGCTAGCCGAGAGGGTTGGCTGCGACG-3' This study 
endo-up-R 5'-CTCAGATCTTCCCGCGCATGAACGGACTCGC-3' This study 
endo-down-F 5'-CTCAGATCTGGTTTTCATCGTCATTCGCTCCT-3' This study 
endo-down-R 5'-CACAAGCTTCATGAAGCGTAAGGCGCGCC-3' This study 
holin-up-F 5'-CTGGCTAGCCGAAAGCGCGTGCGAGCTTC-3' This study 
holin-up-R 5'-GTCAGATCTTGACGTGGCGTTCCCGTTCGC-3' This study 
holin-down-F 5'-GACAGATCTGGCCATGACGGCGATTCCAG-3' This study 
holin-down-R 5'-GTGAAGCTTCCGGCGATAGCTGTCGAGCG-3' This study 
anti-comp-F 5'-GTCTGGATCCCGCTCGATCTCCTGGCGCTG-3' This study 
anti-comp-R 5'-CGGTTCTAGACCGAGGCGGCGGGTTTTCAT-3' This study 
endo-comp-F 5'-CAGTGGATCCTGGCGATGTTCGTCTGCGGC-3' This study 
endo-comp-R 5'-CGGTTCTAGATTTCGCGGCGAGTCCGTTCA-3' This study 
holin-comp-F 5'-CTGTGGATCCCCGTCTACCTGCCGCCGTTC-3' This study 
holin-comp-R 5'-CGGTTCTAGACGAACGGGAACGCCACGTCA-3' This study 
Added restriction site is underlined 
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PCR reactions were conducted for 30 cycles with  parameters as follows: 
denaturation at 95°C for 1 min; annealing at 62°C, 65°C, 65°C, 60°C, 64°C, 63°C for 
primer sets anti-up, anti-down, endo-up, endo-down, holin-up, and holin-down, 
respectively; and extension at 72°C of 1 min for all reactions.  All constructed plasmids 
were confirmed by restriction endonuclease digestion.  All plasmid constructs were 
performed using E. coli DH5α MCR as a host.  Plasmid constructs were introduced by 
chemical transformation (92), followed by selection on LB agar amended with 30 µg/ml 
Km at 30°C. 
Site-directed mutagenesis.  Plasmids pMo130::antiholin, pMo130::endolysin, 
and pMo130:: holin were individually introduced into B. cenocepacia BC0425 by 
conjugation, using triparental matings with pRK2013 as the mobilizing plasmid.  Donor, 
mobilizer, and recipient suspensions were made in LB broth from cultures grown on 
solid media under selective conditions, as appropriate for 18 h.  Bacterial suspensions 
were adjusted spectrophotometrically (A600= 0.5), mixed at an equal ratio (1:1:1), and 
transferred to a positively charged sterile membrane layered on a 100 x 15 mm LB agar 
petri dish.  Following an 18 h incubation period at 37°C, the cells from the mating and 
respective controls were washed twice in phosphate buffer (0.125 M, pH 7.1) by 
centrifugation (12,096 X g for 10 min at 5°C).  The bacterial pellets were suspended in 
phosphate buffer and dilution plated to LB agar plates amended with 600 µg/ml Km and 
20 µg/ml Tc for selection of single crossover events.  Transconjugants were sprayed 
with 0.45 M pyrocatechol to identify colonies in which single crossover events had 
occurred. Co-integrates exhibited a yellow color because xylE encodes for catechol 2,3-
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dioxygenase, which catalyzes the ring cleavage of pyrocatechol and converts the 
colorless substrate to an intensely yellow hydroxymuconic semialdehyde (41).  YTSA 
was used to select for double-crossover events in transconjugants, since the sacB gene is 
contained in plasmid pMo130. Single yellow colonies were grown in YT broth medium 
for five hours and then plated to YTSA to select for resolved co-integrants (41).  The 
colonies were once again sprayed with pyrocatechol.  Presumptive resolved co-
integrants exhibited a white phenotype. To confirm gene deletion, co-integrants were 
analyzed by PCR using multiple primer combinations, both internal and external to the 
target gene deletion.     
Complementation experiments.  Plasmids pMo168::holin-comp, pM0168::anti-
comp and pMo168::endo-comp were individually introduced into strain BC0425 ∆ 
holin, BC0425 ∆ antiholin and BC0425 ∆ endolysin, respectively, by conjugation using 
triparental matings with pRK2013 as the mobilizing plasmid.   The antiholin gene was 
amplified using primers anti-comp-F and anti-comp-R (Table 2.2) and cloned into 
MCS2 of plasmid pMo168, digested with BamHI and XbaI, to obtain plasmid 
pMo168::anti-comp.  Triparental matings (1:1:1) with selection on LB media 
supplemented with 600 µg/ml Km and 20 µg/ml Tc, were performed as described above 
to mobilize pMo168::antiholin-comp into BC0425 ∆ antiholin. Transconjugants were 
sprayed with 0.45 M pyrocatechol to identify colonies which contained the pMo168 
derivative plasmid.   
The endolysin gene was amplified using primers endo-comp-F and endo-comp-R 
(Table 2.2) and cloned intoMCS2 of plasmid pMo168, digested with BamHI and XbaI, 
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to obtain plasmid pMo168::endo-comp.  Triparental matings with selection on LB media 
supplemented with 600 µg/ml Km and 20 µg/ml Tc were performed as described above 
to mobilize pMo168::endo-comp into BC0425 ∆ endolysin.  Transconjugants were 
sprayed with 0.45 M pyrocatechol to identify colonies which contained the pMo168 
derivative plasmid.   
The holin gene was amplified using primers holin-comp-F and holin-comp-R 
(Table 2.2) and cloned into MCS2 of plasmid pMo168, digested with BamHI and XbaI, 
to obtain plasmid pMo168::holin-comp.  Triparental matings with selection on LB media 
supplemented with 600 µg/ml Km and 20 µg/ml Tc were performed as described above 
to mobilize pMo168::holin-comp into BC0425 ∆ holin.  Transconjugants were sprayed 
with 0.45 M pyrocatechol to identify colonies which contained the pMo168 derivative 
plasmid.   
PCR reactions were conducted for 30 cycles and parameters as follows: 
denaturation at 95°C for 1 min; annealing at 65°C, 63°C,  and 64°C for primer sets anti-
comp, endo-comp, and holin-comp, respectively; and extension at 72°C of 1 min for 
each reaction.  All constructed plasmids were confirmed by restriction endonuclease 
digestion.  All plasmid construction was performed using E. coli DH5α MCR as a host.  
Plasmid constructs were introduced by chemical transformation as described by 
Sambrook et al. (92), followed by selection on LB agar amended with 30 µg/ml Km at 
30°C. 
Growth curve experiments.  Deletion mutants BC0425 ∆ antiholin, BC0425 ∆ 
holin, BC0425 ∆ endolysin and BC0425- wild-type (WT) were UV induced and their 
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growth followed by recording optical densities (OD) to observe for lysis.  Suspensions 
were made in 20 ml TN broth from cultures grown on TNA under selective conditions, 
as appropriate for 18 h at 37°C.  Bacterial suspensions were adjusted 
spectrophotometrically (A600= 0.08-0.1) and shaken at 170-200 rpm at 37 ºC.  Once 
cultures attained an A600= 0.5, cultures were centrifuged at 7741 X g for 10 min at 4 ºC 
and the pellet was resuspended in 10 ml of 0.85% NaCl. Centrifugation was repeated 
and pellets were again resuspended in 10 ml of 0.85% NaCl.  The 10 ml suspensions 
were then aliquoted to individual sterile petri plates and UV irradiated (400µw/cm2/sec) 
for 7 sec with constant shaking of the plates.  UV irradiated cells were transferred  to 
500 ml Erlenmeyer flasks with 10 ml 2X TN broth and 30 ml TN broth.  Cultures were 
then grown at 37 º C, with shaking (200 rpm) and the A600 recorded at 30 min intervals. 
Dinitrophenol triggering.  Deletion mutants, BC0425 ∆ antiholin, BC0425 ∆ 
holin, BC0425 ∆ endolysin, and BC0425-WT were UV induced as described above.  
Suspensions were made in 20 ml TN broth from cultures grown on solid media under 
selective conditions, as appropriate for 18 h at 37°C.  Bacterial suspensions were 
adjusted spectrophotometrically (A600= 0.08-0.1) and shaken at 170-200 rpm at 37 ºC 
until the cultures reached an A600= 0.5.  The cultures were centrifuged at 7741 X g for 10 
min at 4 ºC and the pellet was resuspended in 10 ml of 0.85% NaCl. Centrifugation was 
repeated and pellets were resuspended in 10 ml of 0.85% NaCl.  The 10 ml suspensions 
were then aliquoted to individual petri plates and UV irradiated (400µw/cm2/sec) for 7 
sec.  UV irradiated cells were combined in a 500 ml flask with 10 ml 2X TN broth and 
30 ml TN broth, and  grown with shaking (200 rpm) at 37 º C.  At 2 h post UV 
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induction, the protonophore uncoupler dinitrophenol (DNP) was added to the cultures at 
a final concentration of 10 mM and the culture was monitored by optical density.    
Tailocin activity quantification.  Deletion mutants, BC0425 ∆ antiholin, 
BC0425 ∆ holin, BC0425 ∆ endolysin, and BC0425-WT were UV induced as described 
above.  Suspensions were made in 20 ml TN broth from cultures grown on solid media 
under selective conditions, as appropriate for 18 h.  Bacterial suspensions were adjusted 
spectrophotometrically (A600 = 0.08-0.1) and shaken at 170-200 rpm at 37 ºC.  Once 
cultures had grown to an  A600 = 0.5, they were centrifuged at 7741 X g for 10 min at 4 
ºC and the pellet was resuspended in 10 ml of 0.85% NaCl. Centrifugation was repeated 
and pellets were  resuspended in 10 ml of 0.85% NaCl.  The 10 ml suspensions were 
then aliquoted to individual petri plates and UV irradiated (400µw/cm2/sec) for 7 sec.  
UV irradiated cells were combined in a 500 ml flask with 10 ml 2X TN broth and 30 ml 
TN broth.  Cultures were incubated with shaking (200 rpm) at 37ºC.  Two 50 µl samples 
were taken from each culture at 1, 1.5, 1.75, 2, 2.25, 2.5, and 3 h post UV irradiation.  
Samples were either immediately filter sterilized or 50 µl chloroform was immediately 
added.  Chloroformed samples were vortexed and then centrifuged.  The supernatant or 
filtrate was analyzed for tailocin activity using the overlay spot assay as described 
below.  Samples that were filter sterilized represented total amount of extracellular 
tailocin activity.  Intracellular tailocin activity was calculated by subtracting the tailocin 
activity of filter sterilized samples from tailocin activity of chloroformed samples.   
Overlay spot assay.  The overlay spot assay was used to assay for tailocin 
activity.  A suspension of B. cenocepacia strain PC184 was made in TN broth from 
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cultures grown on TNA for 18 h at 37°C.  The bacterial suspension was adjusted 
spectrophotometrically to A600= 0.3.  Molten TNSA was tempered to 55°C and 5 ml 
dispensed into 13 x100 mm sterile plastic tubes (Falcon). 100 µl of the bacterial 
suspension was then added to 5 ml TNSA, vortexed and overlayed onto a TNA plate.  
Plates were allowed to harden before being used.  Serial dilutions (1:10) of preparations 
were spotted (10 µl) on the overlayed plates in duplicate.  Zones of inhibition were 
indicative of tailocin activity.   
Quantitative tailocin assay.  Quantitative tailocin assays were performed by 
counting surviving bacteria, using a method slightly modified from that described by 
Kageyama et al. (53) and modified by Scholl and Martin (96). In a typical assay, fivefold 
serial dilutions of tailocin in P-buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 8 mM 
MgSO4) was incubated in a microtiter well with a known quantity of target bacteria in P-
buffer, for example, 5 × 108 CFU/ml, for 40 min at 37°C. The samples were then serially 
diluted and 100 µl aliquots spotted on TN agar plates to count surviving bacteria. Killing 
units were calculated based on calculations proposed by Scholl and Martin (96).  A 
bactericidal event is the death of a bacterium from contact with a tailocin particle(s). In 
order to accurately count tailocin particles, one must consider the fact that multiple 
particles may, by chance, attach to a single cell and that some cells may not be contacted 
by a tailocin at all at a given tailocin-to-cell ratio. The number of bactericidal events is 
related to the fraction of bacterial survivors in a Poisson distribution, m = −ln(S), where 
m is the average number of bactericidal events per bacterial cell, and S is the fraction of 
survivors. The total number of bactericidal events per ml equals m times the number of 
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bacterial cells per ml. The microtiter well that has an average of 1 tailocin particle per 
bacterium will yield at or near equilibrium 37% survivors, and the well with an average 
of 2.3 tailocin particles per bacterium will yield 10% survivors.  It was within this 
survival range that the m values were calculated (96).  
Calculation of efficiency of killing.  Burkholderia cenocepacia strains BC0425 
and BC0425 ∆ bctN were UV induced as described above.  Tailocin lysates, along with 
an ovalbumin standard, were run on a 10-20% Tris-Tricine SDS gel (BioRad) at 80 volts 
for 4 h.  The gel was stained with Coomasie blue and destained as described by the 
manufacturer (BioRad).  The gel was then scanned and the intensity of the ovalbumin 
standard bands was analyzed using the BioRad Quantity One program.  A standard curve 
was plotted as nanograms vs. intensity.  The intensity of the sheath protein was 
compared to the standard curve to calculate the total amount of sheath protein loaded on 
the gel in nanograms.  Since the molecular weight of the sheath protein was known 
(43kDa), the total number of molecules that were loaded on the gel could be calculated.  
The amount of sheath molecules in one tailocin particle was then estimated based on the 
length and number of sheath proteins contained in bacteriophage P2.  Bacteriophage P2 
has a tail that measures 135 nm and contains 200 sheath proteins/phage tail (62).  
Bcep0425 was determined to be 140 nm in length, which calculated to ~ 207 sheath 
molecules/tail.  The total number of tailocins/ml was then calculated to be equal to the 
total # of sheath molecules/ 207 sheath proteins/tail.  The efficiency of killing (EOK) 
was then calculated by taking the total number of killing events (described above)/ total 
number of tailocins/ml.   
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Transmission Electron Microscopy (TEM).  TEM was performed using high 
titer UV induced lysates spotted onto 400 mesh carbon-coated copper grids and 
negatively stained with 2% (wt/vol) uranyl acetate. The samples were visualized with a 
JEOL 1200EX at an accelerated voltage of 100 kV. 
 
RESULTS 
 
Mass spectrometry of tailocin proteins.  To identify tailocin Bcep0425, a 20 X 
20 test matrix of B. cenocepacia clinical isolates, in which all isolates served as 
producers and indicators, was used to determine production of bacteriocins.  Evaluation 
of strains grown on a solid medium matrix, followed by chloroform treatment, and 
overlayed with each indicator strain revealed that B. cenocepacia strain BC0425 
produced a small zone of inhibition when evaluated as a producer.  The observation of a 
small zone indicated the potential production of a tailocin by strain BC0425.  The 
presence of a tailocin in UV induced lysates was confirmed by Guichun Yao by UV 
induction studies and examination of concentrated lysates by electron microscopy.  The 
electron microscopy studies showed the presence of a tailocin (Fig. 2.1)  
A purified tailocin preparation was analyzed for its protein components.  The 
molecular weights of the Bcep0425 major protein subunits were approximated to be 17 
kDa, 30 kDa, 43 kDa and 100 kDa (Fig. 2.2).  The major protein subunits were excised 
from gels and subjected to Liquid Chromatography- MS/MS.  Analysis of peptide 
sequences of tailocin Bcep0425 determined that the 17 kDa protein had highest 
homology to a major tail tube phage protein.  The peptide sequence for the 43 kDa 
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Fig. 2.1.  Electron micrograph of Bcep0425 tailocin following UV induction.  
Samples were stained with 2% (wt/vol) aqueous uranyl acetate. Bar =100 nm 
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FIG. 2.2.  Molecular weights of Bcep0425 major proteins.  Protein subunits of tailocin 
Bcep0425 were dissociated as described in Materials and Methods and loaded on (A) 10-
20% Tris-HCl SDS gel and (B) 7.5% Tris-HCl SDS gel.  Proteins were visualized using 
Coomassie blue staining. 
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protein had significant homology to a putative phage major tail sheath protein, the 30 
kDa protein to a tail fiber assembly protein and the 100 kDa protein to a tail fiber protein 
(Fig. 2.3).  All four proteins revealed striking homology to putative phage proteins 
encoded by B. cenocepacia J2315 chromosome I.  A 23 kb region on chromosome 1 of 
B. cenocepacia J2315, spanning position 100,400 to 124,000 (BCAL0081 to 
BCAL0107), encodes for 27 phage related proteins.  The proteins in this region consist 
mainly of tail proteins and do not consist of proteins related to capsid formation or DNA 
metabolism, indicating that the region may code for a tailocin.  This is consistent with 
the genetic organization of pyocins from Pseudomonas.  
Overview of the tailocin Bcep0425 gene cluster.  A total of 537 contigs were 
predicted from the assembled BC0425 sequence data.  Known protein sequences, 
obtained from the MS data of Bcep0425 (Fig. 2.3), were used to search and identify the  
potential contigs containing the tailocin genes.  A 23 kb contig (contig 77) was 
determined to contain the Bcep0425 sequence. Blast analysis of contig 77 revealed that 
the tailocin sequence had 99% nucleotide sequence identity to an identified putative 
tailocin found on chromosome I encoded by B. cenocepacia strain J2315 (BCAL0081 to 
BCAL0107).  Interestingly, the J2315 putative tailocin contained a 1.9 kb insertion, 
identified as a Group II intron, between genes showing homology to Bcep0425 gene8 
and gene9.   
The identified Bcep0425 gene cluster had an average GC content of 69%, which 
was slightly higher than the 66% GC content of B. cenocepacia strain J2315 and the 
67% GC content of BC0425.  A total of 29 protein coding genes were predicted to be  
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A. 
Bcep0425 (17kD)             35 MEDYQGGGMSGPIKVDFGQEGIQLE 59 
B. cenocepacia (J2315) phage major tail tube      35 MEDYQGGGMSGPIKVDFGQEGIQLE 59 
B. ubonensis (Bu) phage major tail tube       33  MEDYQGGGMSGPIKVDFGQEGIQLE 57 
 
B. 
Bcep0425 (43kD)            36 ADADASAFPLNTPVLLTNVVAALGK 60 
B. pseudomallei (13177) phage major tail sheath  36 ADADASAFPLNTPVLLTNVVAALGK60 
B. cenocepacia (J2315) phage major tail sheath    36 SDADATAFPLDTPVLLTNVVAALGK60 
Enterobacteria phage P2 major tail sheath    35 SDADAETFPLNKPVLITNVQSAISK59 
 
C. 
Bcep0425 (30kd)             36 TLDAPPARTPTTWPFYRNDVWTLLP 60 
B. cenocepacia (J2315) hypothetical protein    36 TLDAPPARTPTTWPFYRNDVWTLLP 60 
B. pseudomallei(13177) tail fiber assembly     36 TLDAPPARTPTTWPFYRDGAWFLLP 60 
 
D.   
Bcep0425 (100kD)        56 SFGGANVAPDTIHTTLK 72 
B. cenocepacia (J2315) phage tail protein        56 SFGGANVAPDTIHTTLK 72 
B. thailandensis (E264) phage-related tail fiber  56 TFGGENVAPDTVHVVIQ 72 
 
 
FIG 2.3.  Amino acid sequence alignment of Bcep0425 proteins.  Sequence alignment of 
the (A) 17 kD Bcep0425 subunit (B) 43 kD Bcep0425 subunit (C) 30 kD Bcep0425 
subunit and (D) 100 kD Bcep0425 subunit aligned with putative phage proteins.  Amino 
acid residues that are identical are shaded.   
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encoded by the Bcep0425 gene cluster (Fig. 2.4; Table 2.3).  Bcep0425 genes were 
organized into two transcriptional units with all genes, except gene8 and gene9, 
transcribed from the reverse strand (Fig. 2.4).  The Bcep0425 gene cluster was divided 
into four functional clusters, beginning from the left end (negative strand): replication 
regulation, tail/tail fiber morphogenesis, and host lysis (Fig. 2.4).  The order of these 
functional clusters and the arrangement of genes within the clusters was the same as the 
putative tailocin found in strain J2315 (BCAL0081 to BCAL0107).   
Functional assignments for predicted Bcep0425-encoded proteins. (i) 
Integration and replication.  Genes responsible for phage integration are among the 
predicted genes expected to be found within temperate phage genomes.  Integration 
occurs by site-specific recombination mediated by the phage-encoded integrase (38).  
Pyocins are often regarded as phage tails that became evolutionarily specialized as 
bacteriocins, rather than as simple defective phages (81).  Genes for head formation, 
replication, or integration have not been associated with pyocin gene clusters in P. 
aeruginosa (81).  Gene1 of tailocin Bcep0425 is predicted to encode an integrase (Table 
2.3).  gp1 has a conserved C-terminal integrase domain and significant sequence  
similarity to the integrase from phage P22.  Thirteen Bcep0425 gp1 homologues 
exhibiting over 70% identity in sequenced Burkholderia genomes were identified.  To 
our knowledge, this is the first report of a phage integrase to be associated with a high-
molecular weight bacteriocin gene cluster, providing direct evidence that tailocin 
Bcep0425 is a defective phage.    
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FIG. 2.4. Bcep0425 tailocin gene cluster.  Map of tailocin Bcep0425 gene cluster with genes drawn to scale on forward and 
reverse strands.  The Bcep0425 gene cluster is divided into four functional clusters: replication, regulation, tail morphogenesis 
and lysis.  The assigned function of each indicated gene is listed in Table 2.
  
29
Table 2.3.  Bcep0425 putative genes and homologues 
GP Annotation Start End Size (AA) Code. Strd.
Representative Homologue 
(Query genome, accession gene) E-value
1 Integrase 69 1145 358 -
Burkholderia cenocepacia  J2315, 
gi|206558485 0
2
Conserved 
Hypothetical 1012 1462 149 -
Burkholderia cenocepacia  J2315, 
gi|206558486 7.57E-54
3
Zinc finger CHC2-
family protein 1840 4362 930 -
Burkholderia ubonensis  Bu, 
gi|167589039 0
4
Conserved 
Hypothetical 4638 4895 85 -
Burkholderia cenocepacia  J2315, 
gi|206558488 7.74E-37
5
Phage transcriptional 
activator protein 5023 5271 82 -
Burkholderia cenocepacia  J2315, 
gi|206558489 3.44E-39
6
Conserved 
Hypothetical 5258 5438 59 -
Burkholderia cenocepacia  J2315, 
gi|206558490 1.10E-24
7
Conserved 
Hypothetical 5453 5668 71 -
Burkholderia cenocepacia  J2315, 
gi|206558491 5.02E-31
8 Putative BctR 5759 6250 163 +
Burkholderia glumae  BGR1, 
gi|238025796 1.61E-35
9 Putative BctN 6568 6864 98 +
Burkholderia cenocepacia  J2315, 
gi|206558494 7.21E-48
10
Phage late control 
gene D protein 7052 8122 356 -
Burkholderia cenocepacia  J2315, 
gi|206558495 0
11 Tail Assembly 8119 8550 143 -
Burkholderia cenocepacia  J2315, 
gi|206558496 7.65E-77
12 Tape Measure 8573 11143 856 -
Burkholderia cenocepacia  J2315, 
gi|206558497 0
13
Tail associated 
protein 11159 11272 37 -
Burkholderia cenocepacia  J2315, 
gi|206558498 4.10E-12
14
Tail associated 
protein 11281 11652 123 -
Burkholderia cenocepacia  J2315, 
gi|206558499 9.08E-61
15 Tail Tube/Core 11728 12237 169 -
Burkholderia cenocepacia  J2315, 
gi|206558500 7.30E-94
16 Tail Sheath 12266 13438 390 -
Burkholderia cenocepacia  J2315, 
gi|206558501 0
17 Tail Fiber Assembly 13493 14191 232 -
Burkholderia ubonensis  Bu, 
gi|167589026 2.23E-96
18 Tail Fiber 14207 16858 883 -
Burkholderia cenocepacia  J2315, 
gi|206558503 0
19
Tail associated 
protein 16865 17407 180 -
Burkholderia cenocepacia  J2315, 
gi|167589024 2.76E-87
20 Baseplate 17400 18314 304 -
Burkholderia cenocepacia  J2315, 
gi|206558505 7.83E-169
21 Baseplate Assembly 18670 19479 269 -
Burkholderia cenocepacia  J2315, 
gi|206558506 1.41E-61
22 Baseplate Assembly 18311 18673 120 -
Burkholderia cenocepacia  J2315, 
gi|206558507 4.89E-151
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Table 2.3- Continued 
23 Tail Completion 19865 20314 149 -
Burkholderia cenocepacia  J2315, 
gi|206558508 1.03E-77
24 Rz1 20310 20594 95 -
Burkholderia  phage phi52237, 
gi|53722100 6.92E-17
25 Rz 20431 20871 146 -
Burkholderia cenocepacia  J2315, 
gi|206558509 1.09E-73
26 Endolysin 20868 21725 285 -
Burkholderia cenocepacia  J2315, 
gi|206558510 8.97E-158
27 Antiholin 21722 21988 88 -
Burkholderia cenocepacia  J2315, 
gi|206558511 2.21E-40
28 Holin 21990 22334 114 -
Burkholderia cenocepacia  J2315, 
gi|206558512 2.78E-54
29 Tail Protein X 22351 22557 68 -
Burkholderia ubonensis  Bu, 
gi|167589010 5.07E-27
Abbreviations: GP, gene product; Code. Strd., coding strand;  AA, amino acid 
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The Bcep0425 tailocin cassette was found to have integrated into a tRNA-Arg 
gene within the host chromosome (Fig. 2.5A).  Nucleotide sequence analysis for attP, 
attB, attL or attR revealed a 31 bp core sequence (Fig. 2.5B). In attB this 31 bp sequence 
consists of the 3’ end of a putative tRNA-Arg(AGG) gene.  Phage DNA integration 
restores the putative tRNA-Arg(AGG) gene in attL.  Phages often integrate into essential 
genes without inactivating them by repeating the 3’ end of the gene within the phage  
attP site with very few changes, so that when the phage integrates, the normal 3’ end of 
the gene is replaced by the very similar phage-encoded sequence (110).     
  gene3 was predicted to encode a zinc finger CHC2-family protein (Table 2.3).  
This group of proteins is recognized to bind DNA, RNA, protein and/or lipid substrates 
(32, 39).  Gp3 had a conserved topoisomerase-primase (TOPRIM) domain that has been 
reported in the active site regions of bacterial DnaG-type primases and their homologs 
(4). Primases synthesize RNA primers for the initiation of DNA replication.   
 (ii) Regulation.  gene5 encoded a phage transcriptional activator protein (Table 
2.3).   Gp5 contained a conserved Ogr/Delta domain similar to that of phage P2.  P2 
phage Ogr proteins possess one domain but function as dimers, whereas the P4 phage 
delta protein contains two such domains attached covalently (40).  The Ogr protein  
belongs to a class of zinc-binding transcriptional activator proteins (61) and in phage P2 
the Ogr protein functions as a positive regulator of transcription from the P2 late 
promoters (36). 
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B. 
 
 
Fig. 2.5.  Site specific integration of tailocin Bcep0425 in B.cenocepacia BC0425 
genome.  (A) The tailocin Bcep0425 gene cluster was found to be located in the middle 
of a tRNA-Arg gene.  The diagram is not drawn to scale.  (B) DNA sequences within 
attB, attP, attL and attR.  The 31 bp core sequences, where recombination occurs, are 
shown in bold.  Short segments of sequence surrounding core sequence are shown in 
lower case letters.  Bacterial sequences are in blue and phage sequences are in red.   
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Gp8 was identified as a lambda cI-like repressor based on the presence of a 
helix-turn-helix domain.  DNA-binding domains are characteristic of repressors such as 
Cro and CI (2, 84).   
(iii) Tail morphogenesis.  The tail genes (gp11 to gp23) of Bcep0425 possess 
protein and gene order similarity to tail genes of bacteriophage P2 (Fig. 2.6).  The tail 
homologues from phage P2 ranged from 49% to 77% in similarity at the amino acid 
level.   Eleven Bcep0425 tail encoded proteins could confidently be correlated to P2 
equivalents.  The tape measure (gene12), tail fiber assembly (gene17) and tail fiber 
(gene18) genes were the only genes that did not show significant homology to P2, but 
were identified based on homology to putative phage tail structural genes identified in 
Burkholderia sequences.   
A large body of experimental results has shown that the host range of tailed 
phages/pyocins is determined by the tail fibers (38, 119). During adsorption of the virion 
to the host, the tail fiber recognizes and binds reversibly to a receptor on the surface of 
the bacterial cell. Since the tail fibers determine specificity, it is common to find 
significant differences among the tail fibers of phage/pyocins.  The amino acid 
sequences, of the R-type pyocin tail fiber assembly (TFA) proteins, differ considerably 
in the C-terminal region (119).    A comparison of the Bcep0425 TFA amino acid 
sequence with that of a putative tailocin, found on chromosome 1of B. cenocepacia 
strain J2315, (BCAL0096) revealed large differences within the C-terminal region of the 
TFA, as might be expected (Fig.2.7).  Electron microscopy studies of UV induced J2315 
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Fig. 2.6.  Genome maps of tailocin Bcep0425 and Burkholderia phage KL3 prophage elements.  Genome maps of Bcep0425 
and KL3 with genes drawn to scale on forward and reverse strands are shown.  Gene organization of Bcep0425 and phage 
KL3 are nearly identical.  Bcep0425 does not contain genes involved in capsid morphogenesis and DNA modification.  
Homologues of genes indicated in pink are present in phage P2.  
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FIG. 2.7.  Alignment of the amino acid sequence of Bcep0425 tail fiber assembly (TFA) 
with the TFAs of tailocin J2315 and phage KL3.  The TFA gene product amino acid 
sequence deduced from the nucleotide sequence is aligned with those of tailocin J2315 
and phage KL3.  Amino acid residues that are identical are shaded.  Gaps are shown 
with dashes.       
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supernatants revealed the presence of a tailocin; however, the activity was not confirmed 
due to lack of a sensitive host (Fig. 2.8).  Additionally, the BCAL0081 to 
BCAL107sequence was not confirmed to encode for the detected tailocin.  The TFA of 
Bcep0425 showed 73% homology to the annotated sequence of the TFA of the recently 
identified temperate phage KL3, isolated from B. cenocepacia strain CEP511 (71).  
Phage KL3 was reported to only have one sensitive host.   In a three-way alignment of 
the amino acid sequence of the TFA proteins of tailocin Bcep0425, putative tailocin 
J2315, and phage KL3, the largest divergence was observed at the C-terminal sequence.   
A further comparison of tailocin Bcep0425 to phage KL3 showed that they had 
identical gene organization in genes involved in transcription/translation, regulation, tail 
morphogenesis and lysis (encoded from left to right on the negative strand) (Fig. 2.6).  
However, tailocin Bcep0425 as compared to phage KL3, lacked genes involved in 
capsid formation and DNA modification (Fig. 2.6).  Greater than 60% identity was 
observed in the 29 identified Bcep0425 genes with that of KL3, except for gene1 
(putative integrase), gene2 (hypothetical protein) and gene6 (hypothetical protein), 
which had 6, 3, and 12 %, identity, respectively.   
 (iv) Host cell lysis.  The Bcep0425 lysis cassette consisted of gene24, gene25, 
gene26, gene27, and gene28 and is organized similarly to the lambda lysis cassette with 
SRRzRz1equivalents.  Only the endolysin is usually identifiable by a homology search.  
The endolysin, gene26, was identified based on the presence of a peptidoglycan binding 
domain (PFAM01471).  This domain is found at the N or C terminus of a variety of 
enzymes involved in bacterial cell wall degradation (31, 59).   
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Fig. 2.8.  Electron micrograph of concentrated filtered lysate of UV induced B. 
cenocepacia strain J2315.  The putative tailocin particles produced by J2315 are shown 
in micrograph.  Sample was stained with 2% (wt/vol) aqueous uranyl acetate.  Bar = 100 
nm 
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Bcep0425 gene27 and gene28 encoded the antiholin and holin, respectively.  The 
holin and antiholin are two entirely separate genes, which is characteristic of the P2 lysis 
cassette (127).  Holins are a very diverse group of proteins that contain at least one 
transmembrane domain (TMD).  To date, three different types of canonical holins have 
been identified: class I (3 TMDs), class II (2 TMDs), and class III (1 TMD) (121).  The 
Bcep0425 holin contained 4 TMDs, with a N-in and C-in topology (Fig. 2.9), which was 
designated as a Class IV holin.  The Bcep0425 holin spanned 114 residues and contained 
a hydrophilic, cytoplasmic C-terminal domain.    
Antiholins are specific inhibitors of holins and like holins, are very diverse (121).  
The only characteristic of antiholins is they always contain at least one TMD.  The 
antiholin of Bcep0425 contained two TMDs with an N-out and C-out topology (Fig. 
2.9).  The presence of an aspartic acid residue at position 63 interrupted a third TMD.   
The spanin complex, which consists of the Rz and Rz1, span the periplasm 
during lysis.  The proteins are thought to undergo a conformational change and cause 
disruption of the outer membrane (OM) (56, 124, 126).  The spanin components, gene24 
(Rz1) and gene25 (Rz), were identified by their characteristic gene architecture.  The Rz1 
encodes an OM lipoprotein, with a signal-peptidase II cleavage site, embedded out of 
frame within Rz  (Fig. 2.10).  Like other Rz proteins, the Bcep0425 Rz had an N-terminal 
TMD and a C-terminal periplasmic domain that was exceptionally rich in acidic and 
basic residues (Fig. 2.10).  However, the Bcep0425 Rz1 was not completely embedded 
within the Rz, like the lambda spannin genes (126).  The Rz1 of Bcep0425 overlapped 
Rz, which is characteristic of the phage P2 spanin genes (104).  The Rz and Rz1 of  
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(A) Holin 
Holin 
       -                                                           -                                                + -          + +                                           -  
MAEPNLTTAAMLSTAIGVAGLAPGIDGNALIGAFTGAALVVVTSKEIGVARRAAYLLISLVMGYLAAPEI 
10                      20                      30                     40                      50                     60                       70 
 
                                                                        - +  +      -              ++   
VGATPIHSTGVAAFFAAALVIAVTLQLIERIKTLDLLALFRKGG 
                    80                       90                  100                   110     
 
   
(B) Antiholin 
                                                +           ++         +    ++                                                  -                               -        
MAFPFALIALAAHLAVLVRVLTYRRNGARHRRHASWFAWMLVAVTGGASIEWLLHTGAVGFFDAATAVFL 
                   10                        20                        30                         40                       50                       60                      70 
 
                    +            +     +   - 
AMFVCGTRGNVARLLRSE 
                       80    
 
 
FIG. 2.9.  Predicted transmembrane domains (TMD) of the Bcep0425 holin and 
antiholin.  The predicted TMDs of the Bcep0425 holin and antiholin are indicated in 
yellow, and the charged residues are indicated by + or -.   
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 (A) Rz 
ATGAACGGACTCGCCGCGAAAATCATCGCGTGGATCGTCGCGCTCGCCACGTGCGCCGTC 
 M  N  G  L  A  A  K  I  I  A  W  I  V  A  L  A  T  C  A  V  
                   + 
GTCGCGCTGTACGTGCATGGGCTGCGCGCCGAGCGCGCGACCGCGCAACGGCAACGCGTC 
 V  A  L  Y  V  H  G  L  R  A  E  R  A  T  A  Q  R  Q  R  V 
                         +     -  +              +     + 
GAGGCGCAACAGGCGCTCGCCGCGCGCGACGGCGTCATTGCGCGCCTGCGGCAGGACGCC 
 E  A  Q  Q  A  L  A  A  R  D  G  V  I  A  R  L  R  Q  D  A 
 -                       +  -              +     +     - 
GCCGAACGCGCGCAACAGCAGGTGCGGCTCGACCACGCGCAAACCGCCATCGCGTCGAAG 
 A  E  R  A  Q  Q  Q  V  R  L  D  H  A  Q  T  A  I  A  S  K 
    -  +                 +     -                          + 
CTCGACGCCATTCGATTTGAAAACCGGAGATTGACCGATGAAAACGCCGCGCTTCGCGCC 
 L  D  A  I  R  F  E  N  R  R  L  T  D  E  N  A  A  L  R  A 
    -        +     -     +  +        -  -              + 
TGGGCTGATACTCGCCTGCCTGACGACGTTGTCCGCCTGCAAGCCAGTCCCGCTCTCACC 
 W  A  D  T  R  L  P  D  D  V  V  R  L  Q  A  S  P  A  L  T 
       -     +        -  -        +     
GGCGCCGGCGATTATGTCGAACACGTGCCAGACGGTGAAACCGTGCACGCTGCCGAGGCT 
 G  A  G  D  Y  V  E  H  V  P  D  G  E  T  V  H  A  A  E  A 
          -        -           -     -                 - 
CGCGCCGCGGACCAACGGTGA 
 R  A  A  D  Q  R  * 
 +        -     + 
     
 
(B) Rz1 
+      +                                        +                                               +            +        +         -    -                 +       
MKTPRFAPGLILACLTTLSACKPVPLSPAPAIMSNTCQTVKPCTLPRLAPRTNGELDGALTLVKAAWATC 
                     10                     20                     30                      40                     50                       60                        70 
 
            -                                   -                  - 
AATVDMIAACQAGAAAPDHGAHSHD 
                      80                        90    
 
 
Fig. 2.10.  The primary structure of Bcep0425 Rz and Rz1.  (A) Bcep0425 Rz gene is 
shown with predicted translation below.  The predicted N-terminal transmembrane 
domain and Rz1 start codon are highlighted in yellow and underlined, respectively.  (B) 
The predicted lipoprotein signal sequence is highlighted in grey with the processed Cys 
residue highlighted in red.  Charged residues are indicated by + or -.   
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Bcep0425 also showed homology to the lysB and lysC spanin genes of phage P2.  This 
homology, combined with the structural features, allow the conclusion that genes 24 and 
25 were the Rz1 and Rz, respectively.   
Confirming the role of the holin, antiholin, and endolysin in host lysis.  To 
confirm the role of the putative holin, antiholin, and endolysin in host lysis, deletions of 
each gene in BC0425 were made using the system developed by Hamad et al. (41) that  
generated unmarked and in-frame deletion mutants.  This system relies on the use of a 
suicide plasmid pMo130, which harbors a reporter xylE that allows for reliable visual  
detection of Burkholderia transformants and a modified sacB that allows for the 
resolution of co-integrants. 
BC0425∆ holin, BC0425∆ antiholin, BC0425∆ endolysin, and BC0425-wild 
type (WT) were UV induced and their growth followed by recording optical density at 
600 nm (OD600) to observe for lysis, if any.  UV induction of BC0425-WT resulted in an 
increase in OD600 for 2 h post induction with an observed sudden drop in OD600 , which 
indicated host lysis.  Inactivation of the lambda holin results in a distinctive phenotype, 
in which respiration and macromolecular synthesis continue past the normal lysis time 
(122).  The cells continue to elongate and not lyse due to the inability of the endolysin to 
reach the periplasm (122).  BC0425∆ holin exhibited a similar phenotype as that of a λ 
holin mutant.  At 2 h post-induction, the OD600 did not suddenly decrease as observed 
with BC0425-WT (Fig. 2.11).  No lysis of the cells was observed until 2.5 h post 
induction, which has been attributed to the presence of a temperate phage harbored by 
BCO425 (unconfirmed) (Chapter IV).   
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The deletion of the endolysin should also result in the inability of cells to lyse.  In 
λ, deletion of the endolysin does not result in lysis, but cell respiration and 
macromolecular synthesis stop at the normal lysis time (122).  Deletion of the endolysin 
in BC0425 did not result in lysis (Fig. 2.11).  The OD600 continued to increase past the 
normal lysis time (2 h).  These results were consistent with that previously reported for λ 
lysis mutants (33, 46, 87).  It was expected that deletion of the antiholin should result in 
premature lysis of cells since the antiholin would not inhibit holin activity.  This 
phenotype was observed with the BC0425∆ antiholin mutant (Fig. 2.11).  Lysis began to 
occur approximately 30 min earlier than observed for BC0425-WT UV-induced at the 
same time.     
 Lysis triggering using dinitrophenol.  Holins accumulate within the cytoplasm 
and cause lysis of the host cell at a precise genetically programmed time.  Release of the 
endolysin to the periplasm occurs when holin concentrations accumulate to a critical 
level that leads to formation of an oligomeric complex that disrupts the membrane (117).  
Dinitrophenol (DNP) is an uncoupling  protonophore that dissipates the proton-motive-
force (PMF) across the bacterial plasma membrane (51, 87, 122).  A common feature of  
all holin systems is that all holins can be prematurely triggered by membrane 
depolarization with energy poisons such as cyanide and DNP (26).   To further confirm 
the function of the holin in BC0425, DNP was added to cultures at 2 h post-UV 
induction.  Immediately after addition of DNP to BC0425-WT and BC0425 ∆antiholin 
cultures, the OD600 dropped, indicating lysis (Fig. 2.12).  This was expected as both 
strains contained a functional holin protein.   
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FIG. 2.11.  Growth curve of BC0425 and lysis mutants post-UV induction.  Lysis of 
BC0425-WT coincides with sudden drop in OD600.  The OD600 was sampled and 
recorded at 60 min intervals. Results are representative of duplicate experiments. 
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FIG. 2.12.  Addition of dinitrophenol (DNP) to BC0425 ∆antiholin, BC0425 ∆holin, 
and BC0425-WT post-UV induction.  The blue circles represent BC0425-WT, the red 
squares represent BC0425 ∆holin, and the green triangles represent BC0425 ∆antiholin.  
Dotted lines represent the addition of DNP to cultures two hours post-UV induction and 
solid lines represent cultures that did not receive DNP.  Results are representative of 
duplicate experiments. 
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Using the same treatment, lysis was not observed for the ∆holin mutant (Fig. 
2.12).  Lysis was not triggered since there was no accumulation of the holin protein 
within the cytoplasm.  However, a slight drop in OD600 was observed in BC0425 ∆holin 
and may be due to a temperate phage, previously mentioned, carried by BC0425 that 
expresses its own lysis cassette.   
Tailocin activity of UV induced lysis mutants.  The holin and endolysin are the 
only two proteins essential for host lysis by a phage (117).  Deletion of the phage holin 
does not result in lysis of the lysogen cells and as a result cells continue to elongate and 
phage continue to accumulate within the cytoplasm.  In λ, adding cholorform  
 (CHCl3) to an induced holin mutant results in almost instantaneous lysis (7).  This 
procedure allows for the quantification of tailocin both intracellularly and in the 
supernatant of UV induced cultures.  BC0425-WT, BC0425 ∆holin, and BC0425 
∆antiholin were UV induced and two 50 µl samples were taken from each culture at 1,  
1.5, 1.75, 2, 2.25, 2.5, and 3 h post- UV induction.  Samples were either immediately 
filter sterilized or 50µl chloroform was immediately added to assay for extracellular or 
intracellular and extracelluar tailocin activity, respectively.  Chloroform samples were 
centrifuged and the supernatant of both samples was analyzed for tailocin activity using 
the overlay spot assay.  Intracellular tailocin activity was calculated by subtracting the 
tailocin activity of filter sterilized samples from tailocin activity of chloroformed 
samples.  In Fig. 2.13, the intracellular tailocin activity of BC0425 ∆ holin continued to 
increase past the normal lysis time of 2 h.  This indicated that BC0425 ∆ holin did not 
lyse and that tailocin Bcep0425 continued to accumulate within the cells.  The  
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Fig. 2.13.  Intracellular tailocin activity of BC0425-WT, BC0425 ∆antiholin, and 
BC0425 ∆holin post-UV induction.  BC0425-WT, BC0425 ∆holin, and BC0425 
∆antiholin were UV induced and 50 µl samples were taken post-UV induction.   50µl 
chloroform was immediately added to samples, mixed and centrifuged.  The supernatant 
from samples was analyzed for tailocin activity using the overlay spot assay and assayed 
for zones of inhibition.   Intracellular tailocin activity was calculated by subtracting the 
tailocin activity of samples that were filter sterilized from tailocin activity of 
chloroformed samples.  Results are representative of duplicate experiments. 
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intracellular tailocin activity of BC0425-WT only continued to increase until 2 h post 
UV induction (Fig. 2.13).  Minimal intracellular tailocin activity was observed for  
BC0425 ∆ antiholin (Fig. 2.13), since BC0425 ∆ antiholin lysed earlier than WT and 
tailocin Bcep0425 was not able to accumulate intracellularly, as observed for BC0425-
WT.   
The extracellular tailocin activity of UV induced cultures was also quantified.  In 
BC0425-WT, a gradual increase in extracellular tailocin activity was observed as cells 
lysed over a 2 h time period post-UV induction (Fig. 2.14).  Similar results were 
observed for BC0425 ∆ antiholin, except reduced tailocin activity was observed since  
BC0425 ∆ antiholin lysed earlier than BC0425-WT, which resulted in lower 
accumulation of tailocin within the cells (Fig. 2.14).  Only minimal activity was 
observed in the supernatant of BC0425 ∆ holin cells (Fig. 2.14).  The observed slight 
increase at 2.25 h post-UV irradiation was attributed to cell lysis caused by the temperate 
phage integrated in the strain BC0425 chromosome.    
Complementation of lysis mutants.  In trans complementation of BC0425 ∆ 
antiholin, BC0425 ∆ holin and BC0425 ∆ endolysin deletion mutants was achieved 
using plasmids pMo168::anti-comp, pMo168::holin-comp and pMo168::endo-comp, 
respectively.  BC0425::holin-comp, BC0425:: anti-comp, BC0425::endo-comp, and 
BC0425-WT were UV induced and their growth followed by recording OD600 to observe 
for lysis, if any.  UV induction of BC0425-WT resulted in an increase in OD600 for 2 h 
post induction, with a sudden drop in OD600 at 2 h indicating host lysis (Fig. 2.15).  The  
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Fig.  2.14.  Extracellular tailocin activity of BC0425-WT, BC0425 ∆antiholin, and 
BC0425 ∆holin post-UV induction.  BC0425-WT, BC0425 ∆holin, and BC0425 
∆antiholin were UV induced and 50 µl samples were taken post-UV induction.   
Samples were immediately filter sterilized.  The samples were analyzed for tailocin 
activity using the overlay spot assay.    Results are representative of duplicate 
experiments. 
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Fig. 2.15.  Growth curve of Bcep0425 lysis mutant complements post-UV induction.   
Lysis of BC0425-WT coincides with a sudden drop in OD600.  The OD600was sampled 
and recorded at 60 min intervals.  Results are representative of duplicate experiments. 
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BC0425::anti-comp no longer lysed prematurely and lysis capabilities were restored 
(Fig. 2.15).  Lysis was not restored for the BC0425::holin-comp or BC0425::endo-comp.   
Bcep0425 efficiency of killing.  The efficiency of killing (EOK) was calculated 
based on the molecular mass of the 43 kDa tailocin sheath protein and the determined 
amount of tailocin sheath molecules in a partially purified tailocin preparation as 
described in Material and Methods.  Based on this data, one can calculate the number of 
tailocins/ml and the number of killing events/tailocin or the EOK. From multiple 
preparations and assays, the EOK ranged from 0.4 to 0.6, assuming 100% purity of 
tailocins.  A typical preparation of tailocins ranged from 4 × 1011 to 1 × 1012 killing 
units/ml and the total number of tailocin sheath molecules ranged from 1 × 1012 to  
6 × 1012.  Based on this information, the number of killing units to the number of tailocin 
particles was calculated.  For strain PC184, cells are killed by tailocin Bcep0425 at a 
predicted 1:1 interaction. 
 
DISCUSSION 
 
Based on sequence homology and the identification of a bacteriophage lysis 
cassette associated with pyocin gene clusters, studies have shown that pyocin genes 
share a common ancestry with bacteriophages (81).    However, neither a gene for capsid 
formation, replication, nor integration has been found to be associated with pyocin gene 
clusters (78).  This evidence suggests that pyocins are phage tails that became 
evolutionarily specialized as bacteriocins, rather than as simple defective phages (81).  
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We have determined the genetic organization of the Bcep0425 tailocin cluster and have 
identified the major structural proteins and lysis cassette.  Gene1, gene3 and gene5 were 
predicted to encode for an integrase, zinc-finger CHC2-family protein involved in 
replication and a phage transcriptional activator, respectively.   The presence of gene1, 
gene3 and gene5 in the Bcep0425 cluster provides the first evidence for phage associated 
genes to be linked with a pyocin/tailocin gene cluster and indicates that Bcep0425 is a 
defective phage.   
Headless mutants of bacteriophage PS17 have been demonstrated to kill sensitive 
cells with bacteriocin-like activity (100).  Furthermore, it has been shown that 
component exchanges, known as phenotypic mixing, occurred between the R2 pyocin of 
Pseudomonas and phage PS17 (100).  The identified gene products of the Bcep0425 
tailocin cluster showed homology to Burkholderia phage KL3, an identified P2-like 
phage (71).  Tailocin Bcep0425 and phage KL3 were also organized similarly, except 
Bcep0425 did not contain genes involved in capsid formation or DNA modification and 
showed greater than 60 % identity in 26 of 29 homologous genes (Fig. 2.5).     
The presence of a lysis gene cassette in Bcep0425 similar to that contained in 
lytic bacteriophages further supports that tailocin Bcep0425 is a defective phage.  The 
function of the Bcep0425 holin, along with the antiholin and endolysin, were confirmed 
using mutational analysis. Upon analysis of the the Bcep0425 lysis cassette, the holin 
was determined to contain four TMDs with a N-in and C-in topology (Fig. 2.8).   Holins 
are a very diverse group of proteins, but only three classes of canonical holins have been 
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described to date (121).  Class I, II and III holins contain 3, 2 and 1 TMD, respectively.  
We are proposing that the Bcep0425 holin represents a new class of holin, Class IV.  
In complementation studies of lysis gene mutants it was possible to complement 
the antiholin deletion mutant.  However, although the holin and endolysin complements 
were similarly constructed and confirmed by sequence analysis, it was not possible to 
complement the in-frame deletion mutants.  For most bacteriophages, host cell lysis 
requires, at a minimum, an endolysin and a holin.  Holin-dependent lysis systems are 
highly regulated.  The precise temporal regulation is also dependent on the energy state 
of the cytoplasmic membrane (27, 116).  Lysis requires the endolysin to accumulate 
within the cytoplasm until the holin reaches a critical concentration and disrupts the 
membrane (37).  Any alteration in this concentration can retard lysis.  Since pMo168 is a 
low copy plasmid, the BC0425::holin-comp may not have attained the critical 
concentration necessary for membrane disruption.  For BC0425::endolysin-comp, the 
high concentration of endolysin necessary for cell wall degradation was also not attained 
due to the low copy number of the complementing plasmid.     
    The host spectrum determinant of pyocins resides in the tail fiber protein, 
which binds specific receptors on the bacterial cell surface.  Currently R-type pyocins 
are being reengineered to generate novel bactericidal protein complexes by retargeting 
their spectra to other bacterial species and genera by making fusions between the pyocin 
tail fibers and the tail fibers of related bacteriophages (95, 119).  In each example of 
creating novel pyocins, the formation of active particles consistently required co-
expression of the cognate or nearly identical chaperone (TFA) specific for the C-
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terminal portion of the tail fiber (95, 119).  In a three-way alignment of the amino acid 
sequence of the TFA protein of tailocin Bcep0425, putative tailocin of J2315, and phage 
KL3, the largest divergence in the sequence was observed at the C-terminal end (Fig. 
2.6).  In this study, we propose that the C-terminal of the TFA gene is responsible for 
specificity and the broad host range of Bcep0425.   
Numerous studies have focused on the characterization of pyocins, but there have 
been no molecular investigations of tailocins from Burkholderia.  This chapter 
constitutes the first molecular characterization of a phage tail-like bacteriocin from 
Burkholderia and provides evidence that tailocin Bcep0425 is a defective phage.     
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CHAPTER III 
IDENTIFICATION OF THE ADSORPTION SITE FOR BCEP0425 
 
INTRODUCTION 
 
The bacterial lipopolysaccharide (LPS) is the major component of the outer 
surface of Gram-negative bacteria.  LPS contributes greatly to the structural integrity of 
the bacteria and protects the membrane from certain chemical attacks (17).  LPS is 
composed of three different parts: lipid A, core-oligosaccharide, and in some cases the 
O-antigen.    The LPS can also have toxic effects as the lipid A component can cause 
endotoxic shock that manifests as fever or other symptoms such as decreased blood 
pressure and inflammation.  
 The O-antigen consists of repetitive subunits of one to eight monosaccharides, 
which are responsible for much of the immunospecificity of the bacterial cell (17).  The 
O-antigen is highly variable and only found in “smooth” bacteria.  Bacteria that do not 
contain an O-antigen are known as “rough”.  The glycosidic part, known as the core, 
consists of approximately ten monosaccharides and the sugar at the reducing end is 
always alpha-3-deoxy-D-manno-oct-2-ulosonic acid [Kdo] (17).  The lipid moiety, lipid 
A is composed of multiple hydrophobic fatty acids, which anchor the LPS to the 
bacterial membrane and is highly conserved among Gram-negative genera.      
The LPS plays a role in the resistance of members of the Burkholderia cepacia 
complex (Bcc) to the effects of cationic antibiotics (80).  The unusual structure of Bcc 
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LPS lowers the anionic charge of the Bcc cell surface, which inhibits the binding and 
subsequent effects of cationic antibiotics. This is attributed to the fewer amounts of 
phosphate and Kdo found within the core oligosaccharide, as compared to other Gram-
negative bacteria (22, 74, 97).  Additionally, there are 4-amino-4-deoxyarabinose 
(Ara4N) moieties attached to the phosphate residues in the lipid A backbone (22) and D-
glycero-α-D-talo-oct-2-ulopyranolsylonic acid (Ko) attached to the Kdo (48).  Ko is an 
unusual sugar, which is only found in few other bacteria such as Acinetobacter spp. and 
Yersinia pestis (112-114).   
 Both Bcc and Pseudomonas aeruginosa are pathogens in CF patients.  Many 
studies of the core oligosaccharide have drawn comparisons between the two bacteria.  
Bcc LPS contains five times less Kdo than P. aeruginosa (97, 99).  The Bcc LPS also 
contains less phosphorus and more heptose as compared to P. aeruginosa LPS (22, 74).  
There are major differences between the LPS of both genera, but both contain rhamnose 
and glucose as the major components of the core oligosaccharide (48, 74).   
 The LPS of gram-negative bacteria has been found to be a likely adsorption site 
for pyocins (35, 45).  This study reports that the Bcep0425 receptor site was determined 
to be part of the core component of the bacterial LPS and that L-rhamnose and α-glucose 
are the surface receptor sites for tailocin Bcep0425.   
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EXPERIMENTAL PROCEDURES 
 
Bacterial strains, plasmids, and growth conditions.  The bacterial strains and 
plasmids used in this chapter are listed in Table 3.1.  The complex medium TN broth 
(TNB) was used for routine maintenance of cultures (42).  Solid medium, TNA, was 
identical except it lacked KNO3 and was supplemented with 20 g/L agar.  For soft agar 
overlays, TN medium was amended with 7.5 g agar/L (TNSA).  Luria-Bertani (LB) 
medium was used in mating experiments (11).  For counter-selection, co-integrants were 
grown in Yeast-Tryptone (YT) broth, which was made by dissolving 10 g of tryptone 
and 10 g of yeast per liter of water.  Sucrose was added to YT broth at a final 
concentration of 15% (wt/vol) and supplemented with 20 g/L agar (YTSA).  B. 
cenocepacia, Escherichia coli, and P. aeruginosa strains were grown at 37°C.  
Antibiotics were added to the media at the following concentrations: 600 µg/ml 
kanamycin (Km) and 20 µg/ml tetracycline (Tc) for B. cenocepacia; 30 µg/ml Km for E. 
coli. 
DNA manipulations.  Genomic DNA was extracted using a DNeasy kit 
(Qiagen), small-scale plasmid preparation was accomplished using the Miniprep kit 
(Qiagen), and gel extraction and PCR product purification were conducted using 
Quiaquick gel extraction kit and Quiaquick PCR purification kit, respectively (Qiagen).  
All restriction endonucleases, Taq DNA polymerase and T4 DNA ligase were purchased 
from New England Biolabs and were used according to manufacturer protocols.  
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT).   
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Table 3.1.  Bacterial strains and plasmids used in Chapter III 
Strain  Relevant Characteristics Reference or Source 
Burkholderia cenocepacia   
BC0425 Producer of Bcep0425 J. LiPuma 
K56-2 ET12 epidemic lineage, O-
antigen+ 
Sokol et al. (103) 
J2315 ET12 epidemic lineage, O-
antigen- 
Laboratory collection 
PC184 Midwest epidemic lineage, O-
antigen- 
J. LiPuma 
BC0425∆ waaL BC0425, deleted waaL gene, O-
antigen- L-Rham-  
This study 
BC0425∆ waaC BC0425, deleted waaC gene, O-
antigen- L-Rham- Glu- 
This study 
Escherichia coli   
DH5αMCR Cloning strain, F- endA1 hsdR17 
(rk-, mk+) supE44 thi-1 λ- recA1 
gyrA96 relA1 deoR ∆(lacZYA-
argF)- U169 Φ80dlacZ∆M15 
Invitrogen 
Pseudomonas aeruginosa   
PAO1 LPS A+ LPS B+ J. Lam (16) 
PAO1wbpM LPS A+ LPS B- J. Lam (16) 
PAO1wbpL LPS A- LPS B- J. Lam (91) 
PAO1rmlC LPS A- LPS B- L-Rham- J. Lam (90) 
PAO1algC LPS A- LPS B- L-Rham-  Glu- J. Lam (50) 
Plasmids    
pRK2013 Tra+ Mob+ ColE1 replicon, Kmr Laboratory Stock (30) 
pMo130 Suicide vector for allelic exchange 
in Burkholderia; ColE1 ori, RK2 
oriT, xylE, sacB, KmR 
M. Voskuil (41) 
pMo168 Replicative vector for 
Burkholderia; oripBBR1, mob+, 
xylE, KmR 
M. Voskuil (41) 
pMo130:: waaL pM0130 with waaL upstream and 
downstream fragments 
This study 
pmo130:: waaC pM0130 with waaC upstream and 
downstream fragments 
This study 
pMo168:: waaL-comp waaL gene cloned into pMo168 This study 
pMo168:: waaC-comp waaC gene cloned into pMo168 This study 
KmR = resistance to kanamycin.  + and - = positive or negative for phenotype,  
respectively 
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DNA sequence analyses were conducted by the Institute of Developmental and 
Molecular Biology, Gene Technologies Laboratory at Texas A&M University.  
Plasmid construction for allelic exchange.  Since B. cenocepacia strain K56-2 
is clonally related to the sequenced strain J2315 (43, 72), PCR primers for regions 
flanking waaL in strain K56-2 were designed based on J2315 sequences BCAL2404 and 
BCAL2406 (www.sanger.ac.uk/Projects/B_cenocepacia/).  Deletion of waaL and waaC 
genes of strain K56-2 were constructed  using the system developed by Hamad et al. 
(41). To construct plasmid pMo130::waaL to be used for deleting waaL from strain K56-
2, a 1.0 kb fragment upstream of waaL was amplified with primers waaL-up-F and 
waaL-up-R (Table 3.2) and cloned into multiple cloning site (MCS) 1 of  plasmid 
pMo130, digested with NotI and BamHI,  to obtain plasmid pMo130:: waaL-up.  The 1.0 
kb fragment downstream of waaL was amplified using primers waaL-down-F and waaL-
down-R (Table 3.2).  The PCR product was cloned into pMo130:: waaL-up, digested 
with BamHI and XbaI, to obtain pMo130:: waaL.  PCR primers for regions flanking 
waaC in strain K56-2 were designed based on J2315 sequences BCAL3111 and 
BCAL3113 (www.sanger.ac.uk/Projects/B_cenocepacia/).  To construct plasmid 
pMo130:: waaC, used to delete waaC from BC0425, a 1.0 kb fragment upstream of 
waaC was amplified with primers wbxy-up-F and wbxy-up-R (Table 3.2) and cloned 
into MCS1 of plasmid pMo130, digested with NheI and BglII, to obtain plasmid 
pMo130:: waaC-up.  The 1.0 kb fragment downstream of waaC was amplified using 
primers manB-down-F and manB-down-R (Table 3.1).  The PCR product was cloned 
into pMo130:: waaC-up, digested with BglII and HindIII, to obtain pMo130::waaC.   
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Table 3.2.  Primers used in Chapter III 
Primer Relevant Characteristics Reference 
waaL-up-F 5'-GTGCGGCCGCTCGCTTCGCCGAGCACCATG-3' This study 
waaL-up-R 5'-GTGGGATCCTCTGGGCATTTGCCGGGCTGG-3' This study 
waaL-down-F 5'-GTCGGATCCAAGACGCTCCATACGCGCCG-3' This study 
waaL-down-R 5'-GACTTCTAGAGCGCACCATCTCCTGCTCGG-3' This study 
wbxy-up-F 5'-CTGGCTAGCCCCGGGTATTGCGTCGAA-3' This study 
wbxy-up-R 5'-GTCAGATCTCCTACTGGTCGCCGAACGTCGT-3' This study 
manB-down-F 5'-GTCAGATCTCAGCCGGCGACAGACATAAAG-3' This study 
manB-down-R 5'-CGTAAGCTTCAATCGACGTCGCGGATCAGT-3' This study 
waaL-comp-F 5'-GTGGATCCCATGAGCGGGCTGTCGGTGG-3' This study 
waaL-comp-R 5'-CACTTCTAGACAGCAATCGCACGGGCTTGC-3' This study 
waaC-comp-F 5'-CACCTGCAGTCGGTTCGCGTGTGGACAGC-3' This study 
waaC-comp-R 5'-GACGGATCCTATGTCTGTCGCCGGCTGCC-3' This study 
Added restriction site is underlined. 
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PCR reactions were conducted for 30 cycles and parameters as follows: 
denaturation at 95°C for 1 min; annealing at  67°C,  63°C, 65°C, 64°C for primer sets 
waaL-up, waaL-down, wbxy-up, manB-down,  respectively; and extension at 72°C for 1 
min for all reactions.  All constructed plasmids were confirmed by restriction 
endonuclease digestion using appropriate enzyme combinations.  All plasmid constructs 
were performed using E. coli DH5α MCR as a host.  Plasmid constructs were introduced 
by chemical transformation (92), followed by selection on LB agar amended with 30 
µg/ml Km at 30°C. 
Site-directed mutagenesis.  Plasmids pMo130::waaL and pMo130::waaC were 
individually introduced into strain K56-2 by conjugation using triparental matings with 
pRK2013 as the mobilizing plasmid.  Donor, mobilizer, and recipient suspensions were 
made in LB broth from cultures grown on solid media under selective conditions, as 
appropriate for 18 h.  Bacterial suspensions were adjusted spectrophotometrically (A600= 
0.5), mixed at an equal ratio (1:1:1), and transferred to a positively charged sterile 
membrane layered on a 100 x 15 mm LB agar petri dish.  Following an 18 h incubation 
period at 37°C, the cells from the mating and respective controls were washed twice in 
phosphate buffer (0.125 M, pH 7.1) by centrifugation (12,096 X g for 10 min at 5°C).  
The bacterial pellets were suspended in phosphate buffer and dilution plated to LB agar 
plates amended with 600 µg/ml Km and 20 µg/ml Tc for selection of single crossover 
events.  Tranconjugants were sprayed with 0.45 M pyrocatechol to identify colonies in 
which single crossover events had occurred. Co-integrates exhibited a yellow color 
because xylE encodes for catechol 2, 3-dioxygenase, which catalyzes the ring cleavage 
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of pyrocatechol and converts the colorless substrate to an intensely yellow 
hydroxymuconic semialdehyde.  Single yellow colonies were grown in YT broth 
medium for 5 h and then plated to YTSA to select for resolved co-integrants.  Colonies 
grown on YTSA were sprayed with pyrocatechol and presumptive resolved co-integrants 
exhibited a white phenotype. To confirm gene deletion, colonies were analyzed by PCR 
using multiple primer combinations, both internal and external to the target gene 
deletion.     
Complementation experiments.  Plasmids pMo168::waaL-comp and 
pMo168::waaC-comp were individually introduced into strain K56-2 ∆ waaL and K56-2 
∆ waaC, respectively, by conjugation using triparental matings, with pRK2013 as the 
mobilizing plasmid.   The waaL gene was amplified using primers waaL-comp-F and 
waaL-comp-R (Table 3.2) and cloned into MCS2 of plasmid pMo168, digested with 
BamHI and XbaI, to obtain plasmid pMo168::waaL-comp.  Triparental matings (1:1:1) 
with selection on LB media supplemented with 600 µg/ml Km and 20 µg/ml Tc were 
performed as described above to mobilize pMo168::waaL into BC0425 ∆ waaL.  The 
waaC was amplified using primers waaC-comp-F and waaC-comp-R (Table 3.2) and 
cloned into MCS2 of plasmid pMo168, digested with BamHI and PstI, to obtain plasmid 
pMo168::waaC-comp.  Triparental matings (1:1:1)  with selection on LB agar 
supplemented with 600 µg/ml Km and 20 µg/ml Tc were performed as described above 
to mobilize pMo168::waaC into BC0425 ∆ waaC..  Tranconjugants were sprayed with 
0.45 M pyrocatechol to identify colonies that contained the pMo168 derivative plasmid.  
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PCR reactions were conducted for 30 cycles and parameters as follows: 
denaturation at 95°C for 1 min; annealing at 63°C and 66°C for primer sets waaLcomp-F 
and R and waaC-comp-F and R (Table 3.2), respectively; and extension at 72°C for 1 
min.  All constructed plasmids were confirmed by restriction endonuclease digestion.  
All plasmid constructs were performed using E. coli DH5α MCR as a host.  Plasmid 
constructs were introduced by chemical transformation, followed by selection on LB 
agar amended with 30 µg/ml Km at 30°C. 
Tailocin activity quantification.  The overlay spot assay was used to assay for 
tailocin activity as described in Chapter II.   
LPS extraction.  LPS extracts from K56-2 ∆ waaL, K56-2 ∆ waaC, K56-2-wild-
type (WT), J2315, K56-2::waaL-comp and K56-2-waaC-comp were made using the hot 
phenol method based on Westphal and Jann (118), with modifications from Apicella et 
al. (3) and Kato et al. (55).  Bacterial suspensions were made in TN broth from cultures 
grown on solid media under selective conditions, as appropriate for 18 h.  Cultures were 
grown in TN broth to A600= 0.7-0.8 at 37°C with shaking.  The cultures were then 
centrifuged (10,000 X g) at 4°C for 15 min.  Pellets were resuspended in 400 ml 
phosphate buffered saline (PBS) and centrifugation was repeated.  Pellets were 
resupended in 15 ml PBS and transferred to a 50 ml polypropylene tube.  After cells 
were resuspended, 0.5 M EDTA (pH 8) was added to a final concentration of 5 mM and 
lysozyme (Sigma) to a final concentration of 250 µg/ml.  Cells were then incubated at 
30°C for 1 h and then overnight at 4°C.  Cells were sonicated at high power, for 4 x15 
sec on ice, using a 1/8 inch probe tip (QSonica Q55).  The cell sonicates were transferred 
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to a clean, acid-washed 50 ml flask and 1M MgCl2 was added to a final concentration of 
20 mM and DNaseI and RNaseA to a final concentration of 20 µg/ml. The mixture was 
incubated at 37°C, with shaking (150 rpm) for 2 h.  Flasks were then placed into a 68°C 
water bath and incubated for 5 min.  An equal volume of liquid phenol (preheated to 
68°C) was added to the cell sonicates and then vigorously shaken for 3 min at 68°C.  
The mixture was transferred to an ice water bath and shaken for 15 min.  The mixtures 
were transferred to 50 ml Oak Ridge tubes and centrifuged (18,000 X g) at 4°C for 15 
min.  The supernatant was removed and purified by dialysis against double distilled 
sterile water using a 3.5 kDa exclusion membrane.  Dialysis was done for several hours 
at room temperature, then overnight at 4°C, with 3-4 water changes.  The dialysate was 
centrifuged (124,000 X g using a Beckman 60 Ti rotor) for 3 hours at 4°C.  The gel-like 
pellet was resuspended in 1 ml endotoxin free water (Sigma) and lyophilized.  The dry 
weight was determined and resupended in endotoxin free water (Sigma) to a 
concentration of 1-2 µg/ml.   
Electrophoretic analysis of LPS.  LPS samples were analyzed using the 
Laemmli SDS-gel electrophoresis system (60).  LPS preparations were dissociated in 
SDS loading buffer and heated at 90-100ºC for 5 min.  LPS was resolved by running 1.0 
µg of each extract on a 16.5% Tris-Tricine SDS minigel (Bio-rad) for 6 hours at 60 volts 
and visualized by silver staining (107).   
LPS adsorbance assay.  An LPS adsorbance assay was performed using a 
purified tailocin preparation.  The tailocin preparation was diluted (1:10) with [P-buffer] 
(50 mM Tris-HCl pH 7.5, 100 mM NaCl, 8 mM MgSO4).  Serial dilutions (1:10) of LPS 
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extracts were made in P- buffer from 1000 µg/ml to 10 µg/ml.  10 µl of LPS dilution and 
90 µl of tailocin dilutions were mixed and incubated at 37ºC for 30 min.  Tailocin 
activity of the mixtures was assayed using the overlay spot assay as described in Chapter 
II using strain PC184 as the indicator strain. 
Sugar inhibition assay.  The effects of L-rhamnose, D-galactose, α-D-glucose, 
D-fructose, D-glucose, sucrose, lactose, D-cellobiose and D-raffinose on Bcep0425 
adsorption to strain PC184 was determined.   The sugar inhibition assay was performed 
as described by Dawes (24) with minor modifications.  Strain PC184 was grown in 1 L 
TN broth (200 rpm) to an A600=1.  Cells were centrifuged (11,337 X g) at 4°C for 5 min.  
The cells were washed in 40 ml P-buffer, centrifuged, and resuspended in 4 ml P-buffer.  
Two ml of the bacterial suspension (1011 cells/ml) was added to 500 µl of tailocin 
Bcep0425 (1010 tailocin/ml) and 2.5 ml of 1.2 M sugar (final concentration of 0.6 M).  
The 5 ml mixture was incubated at 37°C and 500 µl samples were taken at 0, 1, 3, 6, and 
9 min post mixing.  Samples were immediately centrifuged and supernatants were filter 
sterilized.  A 1:10 dilution was made for each sample in P-buffer, followed by a 1:2 
dilution series that was spotted on the overlay seeded with strain PC184, as described 
above.  Plates were incubated and the titer was expressed as the reciprocal of the highest 
dilution showing inhibition. 
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RESULTS 
 
Inhibitory spectrum of tailocin Bcep0425.  To determine the inhibitory 
spectrum of tailocin Bcep0425, a panel of 102 Burkholderia species was tested for 
sensitivity to tailocin Bcep0425. Seventy-three of the isolates tested (conducted in 
LiPuma laboratory, U of Michigan) were representative of the species belonging to the 
Burkholderia cepacia complex (Bcc).  All isolates were tested by both broth 
microdilution (MIC) and the overlay spot assay using 1:10 serial dilutions of tailocin 
supernatants (range from 1/10 to 1/100,000 dilutions).  Only 17 of the 41 B. cenocepacia 
strains tested were resistant to Bcep0425 (Table 3.3).  Over 70% of the Bcc strains tested 
showed sensitivity to Bcep0425, with 26/29 non-Bcc exhibiting sensitivity (Table 3.3).  
In addition, 50% of P. aeruginosa isolates tested showed sensitivity, as well as 1 of 2 E. 
coli tested.   This is significant since phage-like bacteriocins are known to have narrow 
host ranges and are normally effective against bacteria within the same species (89).  
The results in Table 1 indicate that tailocin Bcep0425 has broad host range activity 
against members of the Bcc, other Burkholderia species and is also effective against 
bacteria from other genera.   
LPS adsorption assay.  Adsorption of pyocins to a susceptible host(s) involves 
specific interaction of the tail fiber with a specific sugar or protein on the surface of a 
susceptible host (78).  In order to determine why Bcep0425 exhibited a broad host range, 
we needed to determine the specific adsorption site of Bcep0425.  The LPS of Gram-
negative bacteria is often an adsorption site for pyocins (35, 45).  An adsorption assay                 
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                       Table 3.3.  Host range activity of Bcep0425 
 
 
 
 
 
 
 
 
 
 
 
All isolates were tested by both broth microdilution (MIC) and top agar spot assay using 
1:10 serial dilutions of tailocin (range from 1/10 to 1/100,000 dilutions).  B. vanimaris, 
B. gladioli and B.glumae are not members of the Bcc.   
 
 
 
 
 
 
Species Sensitive/Total Tested 
B. cepacia 3/3
B. multivorans 9/11
B. cenocepacia 24/41
B. stabilis 2/2
B. vietnamiensis 3/3
B. dolosa 2/3
B. ambifaria 3/3
B. anthina 1/3
B. pyrrocinia 3/3
B. seminalis 1/1
B. vanimaris 0/1
B. gladioli 3/3
B. glumae 23/25
P. aeruginosa 3/6
E. coli 1/2
     Total 81/110
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was conducted to determine if Bcep0425 adsorbed to LPS.  Adsorption studies using 
purified LPS isolated from both resistant and sensitive B. cenocepacia isolates indicated 
that the putative receptor for Bcep0425 was a component of the LPS (Fig. 3.1).  
Increasing amounts of LPS were incubated with tailocin Bcep0425 and allowed to 
adsorb.  A serial dilution of unadsorbed tailocin in supernatants was spotted on a lawn of 
B. cenocepacia strain PC184.  In Fig. 3.1, tailocin activity in the supernatant decreased 
as the amount of LPS increased, indicating that tailocin Bcep0425 was adsorbing to the 
purified LPS.  These results indicated that the adsorption site of Bcep0425 was a 
component of the bacterial LPS and was not a protein moiety.    
Effects of sugars on tailocin adsorption.  In a classic experiment reported by 
Dawes (24),  the interaction of bacteriophage T4 with E.coli B cells in the presence of a 
variety of mono-, di- and trisaccharides, was used to determine the putative T4 glucose-
glucose receptor site.  The proposed rationale was any sugar mimicking the whole or 
part of the phage receptor site would inhibit adsorption of the phage to the cell outer 
membrane.  Sugars unrelated to the receptor would have little effect on adsorption.  To 
putatively identify the sugar(s) involved in Bcep0425 adsorption, a sugar inhibition 
assay was conducted using methods similar to those performed by Dawes (24).  The 
sugars were used to determine the inhibition of adsorption of Bcep0425 to susceptible B. 
cencocepacia PC184 cells by calculating the number of unabsorbed tailocin at different 
time points.  α-D-glucose, L-rhamnose and D-galactose were chosen because they are 
sugars commonly found on the core component of Bcc LPS (83, 111).  α-D-glucose and 
L-rhamnose were found to inhibit 100% of tailocin adsorption (Fig. 3.2).  The control,  
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Fig. 3.1.  Inactivation of Bcep0425 by LPS.  Increasing amounts of LPS were incubated 
with tailocin and allowed to adsorb for 30 min.  A serial dilution (1:2) of unadsorbed 
tailocin in supernatants was spotted on a lawn of PC184.  A zone of inhibition is 
representative of tailocin activity.     
  
 
 
 
 
1 µg/ml 5µg/ml 
10 µg/ml 50 µg/ml 
0 µg/ml (LPS) 
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Fig. 3.2.  Sugar inhibition assay.  Effects of L-rhamnose, D-galactose, α-D-glucose, D-
fructose, sucrose, lactose, D-cellobiose and D-raffinose on tailocin adsorption to B. 
cenocepacia strain PC184.  The titer was expressed as the reciprocal of the highest 
dilution showing inhibition.  *** Indicates sugars that inhibited Bcep0425 tailocin 
adsorption.  Results are representative of triplicate experiments.   
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which did not contain a sugar, did not show adsorption inhibition.  D-galactose did not 
inhibit tailocin adsorption and neither did D-fructose, which is not a normal component 
of bacterial LPS (Fig. 3.2).   
The effects of a di- and tri-saccharides containing glucose were also investigated.  
Only those sugars in which glucose was α-linked to another residue inhibited adsorption 
(e.g. sucrose or raffinose); a β-linkage, as in D-cellobiose and lactose, did not inhibit 
adsorption (Fig. 3.2).  This assay indicated that both α-glucose and L-rhamnose are the 
putative sugar components involved in Bcep0425 adsorption to the B. cenocepacia LPS.    
Sensitivity of P. aeruginosa LPS mutants to tailocin Bcep0425.  Kohler et al. 
(58) recently proposed that LPS plays an essential role both as a protective shield and 
receptor for R-pyocins in P. aeruginosa.  The susceptibility of genetically defined 
isogenic P. aeruginosa LPS mutants to R-pyocins was assayed and the structural 
determinants required for R-pyocin recognition were identified for three R-type pyocins 
(58).  We had previously determined that P. aeruginosa strain PA01 exhibited low 
sensitivity to tailocin Bcep0425.  This observation suggested that LPS mutants of PAO1 
might show sensitivity to Bcep0425 as observed in P. aeruginosa for R-type pyocins 
(58).   To determine if this was the case, defined isogenic P. aeruginosa PA01 LPS 
mutants obtained from Dr. Joseph Lam (University of Guelph) were tested for sensitivity 
to Bcep0425 using the overlay spot assay.     
 Together, the A-band and B-band comprise the O-antigen structure of PAO1-
wild type (WT).  PAO1-WT was shown to have minimal susceptibility to tailocin 
Bcep0425 (Fig. 3.3).  In contrast, the LPS B-band deficient wbpM mutant was 
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Fig. 3.3.  Sensitivity of P. aeruginosa LPS mutants to tailocin Bcep0425 (A) Activity of serially diluted (1:10) tailocin 
Bcep0425 against: (1) PAO1-WT; (2) PAO1wbpM; (3) PAO1wbpL; (4) PAO1rmlC; or (5) PAO1algC. (B) Circled numbers 
indicated in Fig. 3.3A correspond to depicted LPS structure with same number. Putative residues involved in Bcep0425 
adsorption are circled in red.  MAN, mannose; Fuc, fucose; GalN, N-galactosamine; HEP, heptose; NAG, N-
acetylglucosamine; KDO, 2-keto-3 deoxyoctulosonic acid.  
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susceptible to tailocin Bcep0425, suggesting that removing the B-band LPS moieties 
exposes the adsorption site to allow adsorption of tailocin Bcep0425 (Fig. 3.3).  The 
wbpL mutant, deficient in both LPS B-band and A-band synthesis, was also susceptible 
(Fig. 3.3).  A PAO1 rmlC  mutant, devoid of L-rhamnose, was also susceptible because 
the α-glucose residue was still present and accessible to Bcep0425.  However, an algC 
mutant exhibited no sensitivity to Bcep0425 due to loss of both the L-rhamnose and α-
glucose residues (Fig. 3.3).  The PAO1 mutant sensitivity assays further confirmed the 
sugar adsorption assays that indicated that L-rhamnose and α-glucose were the sugar 
components involved in Bcep0425 adsorption.  
Targeted mutagenesis of genes involved in the biosynthesis of the core 
oligosaccharide.  The first Bcc genome to be sequenced was that of B. cenocepacia 
J2315, the reference strain for CF epidemiology (21).  Unfortunately, J2315 has 
displayed major barriers to genetic manipulation and has resulted in the use of a proxy 
strain B. cenocepacia K56-2 for genetic experiments.  K56-2 is clonally related to the 
sequence strain J2315 and is more permissive to gene transfer (21, 33).  Ortega et al. 
(41) constructed a panel of isogenic insertion mutants, in strain K56-2, with various core 
oligosaccharide truncations to determine the genetic components involved in 
biosynthesis of the K56-2 LPS.  They determined the structure of the core 
oligosaccharide for two of the LPS mutants, XOA3 and XOA7.  The mutant XOA3 had 
an insertional mutation in the wbxE, which resulted in the production of a lipid A-core 
oligosaccharide and partial O-antigen component. The XOA7 mutant, which had an 
inactivated waaL gene, resulted in the loss of O-antigen and loss of the terminal L-
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rhamnose, which resulted in a truncated core.  An insertional mutation in waaC of the 
Bcc strain K56-2 resulted in the loss of O-antigen and outer core oligosaccharide surface 
expression (41).   
Strain K56-2 was found to be sensitive to tailocin Bcep0425 and since it was 
genetically malleable, experiments to identify the receptor site were conducted using this 
strain.  The allelic exchange and complementation system developed by Hamad et al. 
(41) was used to obtain deletions in genes in B. cenocepacia strain K-56, involved in 
LPS synthesis. Deletion of the waaL, an O-antigen ligase, predicted a loss of the O-
antigen surface expression in K56-2, and indicates the role of the O-antigen in 
adsorption (83). Deletion of waaC, heptosyltransferase I, involved in lipid A-core 
biosynthesis would also identify the role of core moieties. We predicted that the waaL 
deletion would remain sensitive, whereas the waaC mutant would be insensitive due to 
the loss of L-rhamnose and α-glucose residues.  The sensitivity of the wild type and LPS 
mutants was determined using the overlay spot assay.  
Strains K56-2, J2315, and the K56-2 waaL deletion mutant (∆ waaL) all showed 
similar sensitivity to Bcep0425 (Fig. 3.4).  This was because the L-rhamnose and α-
glucose residues were accessible to the tailocin as shown in Fig. 3.4.  When both 
residues were removed, ∆ waaC, tailocin Bcep0425 is no longer able to adsorb to the 
bacterial surface and cells were not sensitive (Fig. 3.4).     
Data obtained from targeted mutagenesis and sugar adsorption assays in B. 
cenocepacia K56-2, combined with sensitivity studies using PAO1 LPS mutants, 
support that L-rhamnose and α-glucose are the adsorption sites for tailocin Bcep0425.  
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Fig. 3.4.  Sensitivity of Burkholderia LPS mutants to tailocin Bcep0425 (A) Activity of serially diluted (1:10) tailocin 
Bcep0425 against: (1) K56-2; (2) J2315; (3) K56-2 ∆waaL ; or (4) K56-2 ∆waaC . (B) Circled numbers indicated in Fig. 3.4A 
correspond to depicted LPS structure with same number.  Residues involved in Bcep0425 adsorption are circled in red.  HEP, 
heptose; KO, D-glycero-α-D-talo-oct-2-ulopyranolsylonic acid ; KDO, 2-keto-3 deoxyoctulosonic acid; QNAc, β-D-QuiNAc.
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Complementation of LPS mutants.  In trans complementation of K56-2 ∆ 
waaL and K56-2 ∆ waaC deletion mutants was achieved using plasmids pMo168::waaL-
comp and pMo168::waaC-comp, respectively. LPS was extracted from K56-2-WT, 
J2315, K56-2 ∆ waaL, K56-2 ∆ waaC, K56-2:: waaL-comp, and K56-2:: waaC-comp 
and compared using SDS gel electrophoresis.  The ladder-like banding pattern 
corresponded to the presence of polymeric O-antigen, as has previously been shown for 
strain K56-2 (72) (Fig. 3.5).  In contrast, J2315 was devoid of an O-antigen (Fig. 3.5).  
K56-2 ∆ waaL showed a defect in O-antigen production when compared to wild-type 
strain K56-2 (Fig. 3.5) and the lipid A-core region was truncated.  The K56-2 ∆ waaC 
mutant resulted in a severely truncated lipid-A-core region and the loss of an O-antigen 
(Fig. 3.5).  Complementation of both the ∆ waaC and ∆ waaL resulted in restoration of 
O-antigen production and the lipid-A core regions were no longer truncated (Fig. 3.5). 
The sensitivity of the wild type and LPS mutant complements was determined 
using the overlay spot assay.  K56-2, K56-2:: waaL-comp and K56-2::waaC were all 
sensitive to tailocin Bcep0425 (Fig. 3.6).  Sensitivity was restored to K56-2::waaC –
comp, indicative of a clean deletion of the waaC gene.   
 
DISCUSSION 
 
It was recently reported that approximately 68% of Bcc isolates produced 
bacteriocin-like toxins capable of inhibition (6).  However, only a small fraction (16%) 
could be attributed to uncharacterized bacteriocin-like proteins.  Previous studies of  
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Fig. 3.5.  Electrophoretic profiles of LPS extracted from J2315, K56-2 ∆ waaL, K56-2 ∆ 
waaC, K56-2:: waaL-comp, and K56-2:: waaC-comp in comparison to the profile of 
K56-2-WT.  A total of 1.0 µg LPS for each isolate was loaded on a 16.5% 
polyacrylamide gel in a Tricine-SDS system and developed by silver staining as 
described in Materials and Methods. 
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Fig. 3.6.  Sensitivity of Burkholderia LPS mutant complements to tailocin Bcep0425 
Activity of serially diluted (1:10) tailocin Bcep0425 against: (1) K56-2; (2) K56-
2::waaL-comp ; or (3) K56-2::waaC-comp. Zones of growth inhibition are indicative of 
tailocin activity/sensitivity. 
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Gram-negative bacteriocins have described bacteriocins as having a narrow-spectrum.  
These bacteriocins were only active against members of the same species and displayed 
restricted levels of inhibition outside of the producing species (88, 89).  Some 
bacteriocins have been shown to kill more broadly, and they have been implicated as a 
primary mechanism for mediating microbial diversity (57).  We have isolated a phage-
tail-like bacteriocin (tailocin), which exhibits broad host range activity against members 
of the Bcc.  Even more striking is that tailocin Bcep0425 was also effective against 
bacteria from other genera, P. aeuroginosa and E. coli.  In all, over 70% of the Bcc 
strains tested showed sensitivity to Bcep0425, with 26/29 non-Bcc exhibiting sensitivity 
(Table 3.3).  In addition, 50% of P. aeruginosa isolates tested showed sensitivity, as well 
as 1 of 2 E. coli tested.   This is significant since most clinically relevant strains of the 
Bcc have demonstrated in vitro broad-spectrum antibiotic resistance.  The use of tailocin 
Bcep0425 could provide an approach to treat infections caused by multi-drug-resistant 
strains of the Bcc.     
A critical feature for pyocins/tailocins is their ability to recognize and bind to 
their bacterial host cell receptors.  The LPS of Gram-negative bacteria is often an 
adsorption site for pyocins (35, 45).  The Bcep0425 receptor site was determined to be 
part of the outer core component of the bacterial LPS.  Both Bcc and P. aeruginosa 
contain rhamnose and glucose as major components of the core oligosaccharides (48, 
74).  Sugar inhibition assays revealed L-rhamnose and sugars containing an α-glucose 
linkage to be potentially involved in Bcep0425 adsorption (Fig. 3.2).  Kohler et al. (58) 
recently proposed that LPS plays an essential role both as a protective shield and 
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receptor for R-pyocins in P. aeruginosa.  The testing of the sensitivity of genetically 
defined LPS mutants of P. aeruginosa confirmed the role of LPS as a protective shield.  
PA01-WT showed minimal sensitivity to Bcep0425, but mutations in PAO1 LPS 
exposed the Bcep0425 α-glucose and L-rhamnose receptor sites, resulting in sensitivity 
(Fig. 3.3).   The testing of the sensitivity of genetically defined LPS mutants of B. 
cenocepacia, confirmed that L-rhamnose and α-glucose are the Bcep0425 receptor sites 
(Fig. 3.4).  Loss of the L-rhamnose and α-glucose residues in the K56-2 ∆ waaC mutant 
resulted in resistance to tailocin Bcep0425 (Fig. 3.4).  In trans complementation of both 
the ∆ waaC and ∆ waaL resulted in restoration of O-antigen production and the lipid-A 
core regions (Fig. 3.5) and sensitivity to tailocin Bcep0425 was restored to the ∆ waaC 
mutant complement. 
   Recently, there has been interest in R-pyocins as specific bactericidal agents. 
Currently R-type pyocins are being reengineered to generate novel bactericidal protein 
complexes (95, 119). The therapeutic efficacy of engineered R-pyocins has been 
demonstrated exogenously by using food products contaminated by E. coli O157:H7 and 
in vivo in a mouse model of P. aeruginosa peritonitis (95, 96).  Future studies will focus 
on the therapeutic efficacy of Bcep0425 against Bcc infections.   
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CHAPTER IV 
IDENTIFICATION OF COMPONENTS INVOLVED IN CONTROLLING 
PRODUCTION OF BCEP0425 AFTER INDUCTION 
 
INTRODUCTION 
 
The production of pyocins in Pseudomonas aeruginosa is inducible by 
treatments that cause DNA damage (93).  It was first thought that pyocin production was 
regulated by a system similar to the SOS system in Escherichia coli.  In this system the 
cleavage of the LexA repressor catalyzed by activated RecA, resulted in the activation of 
various SOS genes and colicin genes (115).  It was later shown that pyocin synthesis is 
dependent on the RecA and that the LexA repressor is not involved in pyocin production 
(75, 101).  Using P. aeruginosa PAO1 derivative strains defective in the synthesis of R2, 
F2, and S2 pyocins, together with complementation tests, later allowed for the 
identification of  two regulatory genes involved in pyocin production, prtN and prtR, 
(75, 81).  The prtN and prtR were identified upstream of the R2-F2 pyocin genes in 
PAO1 (81).  
According to Matsui et al. (75), the prtN encodes a novel type of positive 
regulator composed of 104 amino acids.  The PrtN protein binds to conserved P boxes, 
which are regulatory sequences located approximately 60-100 bp upstream of the 
ribosomal binding site with a consensus motif of ATTGnn(n)GTnn(n), and activate the 
transcription of pyocin genes.  The PrtR protein (256 amino acids), which shows striking 
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similarity to the cI repressor of Φ80 phage, presents a site of cleavage for activated 
RecA.  The prtN promoter activity is repressed until the cleavage of PrtR by an activated 
RecA.  According to Matsui et al. (75), all three genes are required for the inducible 
production of pyocins, since a mutation of any of the three genes results in the inability 
of the pyocin genes to be induced above basal levels.   
 
This study reports on the identification of a putative positive 
transcriptional regulator, bctN, and a cI-like repressor, bctR, upstream of the tailocin 
Bcep0425 structural genes and lysis cassette.  Deletion mutants of bctN, bctR, and recA 
constructed in BC0425 confirm that all three genes are required for the induction of 
tailocin Bcep0425.    
 
EXPERIMENTAL PROCEDURES 
 
Bacterial strains, plasmids, and growth conditions.  The bacterial strains and 
plasmids used in this chapter are listed in Table 4.1.  The complex medium TN broth 
(TNB) was used for routine maintenance of cultures (42).  Solid medium, TNA, was 
identical except it lacked KNO3 and was supplemented with 20 g/L agar.  For soft agar 
overlays, TN medium was amended with 7.5 g agar/L (TNSA). Luria-Bertani (LB) 
medium was used in mating experiments (11).  For counter-selection, co-integrants were 
grown in Yeast-Tryptone (YT) broth, which was made by dissolving 10 g of tryptone 
and 10 g of yeast per liter of water.  Sucrose was added to YT broth at a final 
concentration of 15% (wt/vol) and supplemented with 20 g/L agar (YTSA).  B.  
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Table. 4.1.  Bacterial strains and plasmids used in Chapter IV 
Strain  Relevant Characteristics Reference or Source 
Burkholderia cenocepacia   
BC0425 Producer of Bcep0425 J. LiPuma 
PC184 Midwest epidemic lineage J. LiPuma 
BC0425∆ bctN2 BC0425, deleted bctN gene This study 
BC0425∆ bctR BC0425, deleted bctR gene This study 
BC0425∆ recA BC0425, deleted recA gene This study 
Escherichia coli   
DH5αMCR Cloning strain, F- endA1 
hsdR17 (rk-, mk+) supE44 thi-1 
λ
-
 recA1 gyrA96 relA1 deoR 
∆(lacZYA-argF)- U169 
Φ80dlacZ∆M15 
Invitrogen 
Plasmids    
pRK2013 Tra+ Mob+ ColE1 replicon, 
Kmr 
Laboratory stock (30) 
pMo130 Suicide vector for allelic 
exchange in Burkholderia; 
ColE1 ori, RK2 oriT, xylE, 
sacB, KmR 
M. Voskuil (41) 
pMo168 Replicative vector for 
Burkholderia; oripBBR1, 
mob+, xylE, KmR 
M. Voskuil (41) 
pMo130:: bctN2 pM0130 with bctN upstream 
and downstream fragments 
This study 
pmo130:: bctR2 pM0130 with bctR upstream 
and downstream fragments 
This study 
pMo130:: recA pM0130 with recA upstream 
and downstream fragments 
This study 
pMo168:: bctN-comp bctN gene cloned into pMo168 This study 
pMo168:: bctR-comp bctR gene cloned into pMo168 This study 
pMo168:: recA-comp recA gene cloned into pMo168 This study 
KmR = resistance to kanamycin.  + and - = positive and negative for phenotype,  
respectively 
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cenocepacia and E. coli strains were grown at 37°C.  Antibiotics were added to the 
media at the following concentrations: 600 µg/ml kanamycin (Km) and 20 µg/ml 
tetracycline (Tc) for B. cenocepacia; 30 µg/ml Km for E. coli.   
DNA manipulations.  Genomic DNA was extracted using a DNeasy kit 
(Qiagen), small-scale plasmid preparation was accomplished using the Miniprep kit 
(Qiagen), and gel extraction and PCR product purification were conducted using 
Quiaquick gel extraction kit and Quiaquick PCR purification kit, respectively (Qiagen).  
All restriction endonucleases, Taq DNA polymerase and T4 DNA ligase were purchased 
from New England Biolabs and were used according to manufacturer protocols.  
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT).   
DNA sequence analyses were conducted by the Institute of Developmental and 
Molecular Biology, Gene Technologies Laboratory at Texas A&M University.  
Plasmid construction for allelic exchange.  Deletion of bctN, bctR, and recA 
genes of BC0425 were constructed using the system developed by Hamad et al. (41).  
PCR primers for regions flanking bctN were designed based on the annotated sequence 
of BC0425.  To construct plasmid pMo130::bctN2 used to delete bctN from BC0425, a 
1.0 kb fragment upstream of bctN was amplified with primers PrtN2-up-F and PrtN2-up-
R (Table 4.2) and cloned into multiple cloning site (MCS) 1 of plasmid pMo130, 
digested with NheI and BglII, to obtain plasmid pMo130::prtN2-up.  The 1.0 kb 
fragment downstream of bctN was amplified using primers prtN2-down-F and prtN2-
down-R (Table 4.2).  The PCR product was cloned into pMo130:: prtN2-up, digested 
with BglII and HindIII, to obtain pMo130:: bctN2.   
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Table 4.2.  Primers used in Chapter IV 
Primer Relevant Characteristics Reference 
prtN2-up-F 5'-GTGGCTAGCAGATCGAGCGGTTGCGCTGCG-3' This study 
prtN2-up-R 5'-CTGAGATCTCGCGCCGATCGTCCCGTTGTC-3' This study 
prtN2-down-F 5'-GTCAGATCTGCGGGCGTCAGCAATCGAGCT-3' This study 
prtN2-down-R 5'-GTGAAGCTTAGCTGTCGATCGGCTGGGTCG-3' This study 
prtR-up-F 5'-GAGGCTAGCCGCCGATACGAAGGGGCCGAG-3' This study 
prtR-up-R 5'-CGCAGATCTACCCATTAACAATTGACGCGCC-3'  This study 
prtR2-down-F 5'-GCAGATCTGAAGTAACGCATCCGCGGGGTG-3' This study 
prtR2-down-R 5'-GTGAAGCTTAGCGCGACAGCTACACGTCGG-3' This study 
recA-up-F 5'-GTGGCTAGCTGACCGGATGGATCTGGCGCG-3' This study 
recA-up-R 5'-CTCAGATCTCAGCGTCTGTTGGAGGCGCGC-3' This study 
recA-down-F 5'-GTGAGATCTGAGTGATGGTTGCGCGCCGAG-3' This study 
recA-down-R 5'-GTGAAGCTTACGGGCTCGGATAGCGGCATG-3' This study 
bctN-comp-F 5'-CACGGATCCTGACTGAGTTTGCGGAGACC-3' This study 
bctN-comp-R 5'-GAGTCTAGAGCGGGAGATCAGTGTGGGGG-3' This study 
bctR-comp-F 5'-CAGCTGCAGACGGCGCGTCAATTGTTAATGG-3' This study 
bctR-comp-R 5'-CTCGGATCCCACCCCGCGGATGCGTTACTTC-3' This study 
recA-comp-F 5'-CTCGGATCCGGAAGATAGCAAGAAGGGCTC-3' This study 
recA-comp-R 5'-CTCTCTAGACTCGGCGCGCAACCATCACTC -3' This study 
Added restriction site is underlined 
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PCR primers for regions flanking bctR were designed based on the annotated 
sequence of BC0425.  To construct plasmid pMo130:: bctR2 used to delete bctR from 
BC0425, a 1.0 kb fragment upstream of bctR was amplified with primers prtR-up-F and 
prtR-up-R (Table 4.2) and cloned into MCS1 of plasmid pMo130, digested with NheI 
and BglII, to obtain plasmid pMo130:: bctR2-up.  The 1.0 kb fragment downstream of 
bctR was amplified using primers prtR2-down-F and prtR2-down-R (Table 4.2).  The 
PCR product was cloned into pMo130:: bctR2-up, digested with BglII and HindIII, to 
obtain pMo130:: bctR2.   
PCR primers for regions flanking recA were designed based on the annotated 
sequence of BC0425.  To construct plasmid pMo130:: recA used to delete recA from  
BC0425, a 1.0 kb fragment upstream of recA was amplified with primers recA-up-F and 
recA2-up-R (Table 4.2) and cloned into MCS1 of plasmid pMo130, digested with NheI 
and BglII, to obtain plasmid pMo130:: recA-up.  The 1.0 kb fragment downstream of 
recA was amplified using primers recA-down-F and recA-down-R (Table 4.2).  The 
PCR product was cloned into pMo130:: recA-up, digested with BglII and HindIII, to 
obtain pMo130:: recA.   
PCR reactions were conducted for 30 cycles and parameters as follows: 
denaturation at 95°C for 1 min; annealing at 64°C, 63°C, 64°C, 63°C, 64°C, 63°C for 
primer sets prtN2-up, prtN2-down, prtR-up, prtR2-down, recA-up, and recA-down, 
respectively; and extension at 72°C for 1 min.  All constructed plasmids were confirmed 
by restriction endonuclease digestion.  All plasmid constructs were performed using E. 
coli DH5α MCR as a host.  Plasmid constructs were introduced by chemical 
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transformation (92), followed by selection on LB agar amended with 30 µg/ml Km at 
30°C. 
Site-directed mutagenesis.  Plasmids pMo130::bctN2, pMo130::bctR2, and 
pMo130:: recA were individually introduced into B. cenocepacia BC0425 by 
conjugation using triparental matings with pRK2013 as the mobilizing plasmid.  Donor, 
mobilizer, and recipient suspensions were made in LB broth from cultures grown on 
solid media under selective conditions, as appropriate for 18 h.  Bacterial suspensions 
were adjusted spectrophotometrically (A600= 0.5), mixed at an equal ratio (1:1:1), and 
transferred to a positively charged sterile membrane layered on a 100 x 15 mm LB agar 
petri dish.  Following an 18 h incubation period at 37°C, the cells from the mating and 
respective controls were washed twice in phosphate buffer (0.125 M, pH 7.1) by 
centrifugation (12,096 X g for 10 min at 5°C).  The bacterial pellets were suspended in 
phosphate buffer and dilution plated to LB agar plates amended with 600 µg/ml Km and 
20 µg/ml Tc for selection of single crossover events.  Tranconjugants were sprayed with 
0.45 M pyrocatechol to identify colonies in which single crossover events had occurred. 
Co-integrates exhibited a yellow color because, xylE encodes for catechol 2,3-
dioxygenase, which catalyzes the ring cleavage of pyrocatechol and converts the 
colorless substrate to an intensely yellow hydroxymuconic semialdehyde.  Single yellow 
colonies were grown in YT broth medium for five hours and then plated to YTSA to 
select for resolved co-integrants.  The colonies were once again sprayed with 
pyrocatechol.  Presumptive resolved co-integrants should exhibit a white phenotype. To 
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confirm gene deletion, co-integrants were analyzed by PCR using multiple primer 
combinations, both internal and external to the target gene deletion.     
Complementation experiments.  Plasmids pMo168::bctN-comp, 
pMo168::bctR-comp and pMo168::recA-comp were individually introduced into strain 
BC0425 ∆ bctN, BC0425 ∆ bctR and BC0425 ∆ recA, respectively, by conjugation 
using triparental matings with pRK2013 as the mobilizing plasmid.  The bctN gene was 
amplified using primers bctN-comp-F and bctN-comp-R (Table 4.2) and cloned into 
MCS2 of plasmid pMo168, digested with BamHI and XbaI, to obtain plasmid 
pMo168::bctN-comp.  Triparental matings (1:1:1)  with selection on LB media 
supplemented with 600 µg/ml Km and 20 µg/ml Tc were performed as described above 
to mobilize pMo168:: bctN-comp into BC0425 ∆ bctn2.  Transconjugants were sprayed 
with 0.45 M pyrocatechol to identify colonies which contained the pMo168 derivative 
plasmid.   
The bctR was amplified using primers bctR-comp-F and bctR-comp-R (Table 
4.2) and cloned into MCS2 of plasmid pMo168, digested with BamHI and PstI, to obtain 
plasmid pMo168:: bctR-comp.  Triparental matings (1:1:1) with selection on LB media 
supplemented with 600 µg/ml and 20 µg/ml Tc were performed as described above to 
mobilize pMo168:: bctR-comp into BC0425 ∆ bctR2.  Transconjugants were sprayed 
with 0.45 M pyrocatechol to identify colonies which contained the pMo168 derivative 
plasmid.   
The recA gene was amplified using primers recA-comp-F and recA-comp-R 
(Table 4.2) and cloned into MCS2 of plasmid pMo168, digested with BamHI and XbaI, 
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to obtain plasmid pMo168::recA-comp.  Triparental matings (1:1:1)  with selection on 
LB media supplemented with 600 µg/ml Km and 20 µg/ml Tc were performed as 
described above to mobilize pMo168::recA-comp into BC0425 ∆ recA.  Transconjugants 
were sprayed with 0.45 M pyrocatechol to identify colonies that contained the pMo168 
derivative plasmid.   
PCR reactions were conducted for 30 cycles and parameters as follows: 
denaturation at 95°C for 1 min; annealing at 62°C, 64°C,  and 62°C for primer sets bctN-
comp, bctR-comp, and recA-comp, respectively; and extension at 72°C for 1 min.  All 
constructed plasmids were confirmed by restriction endonuclease digestion.  All plasmid 
constructs were performed using E. coli DH5α MCR as a host.  Plasmid constructs were 
introduced by chemical transformation, followed by selection on LB agar amended with 
30 µg/ml Km at 30°C. 
Growth curve experiments.  Deletion mutants, BC0425 ∆ bctN, BC0425 ∆ 
bctR, BC0425 ∆ recA and BC0425-WT were UV induced and their growth followed by 
recording the optical density at 600 nm (OD600 ) to observe for lysis, if any.  Suspensions 
were made in 20 ml TN broth from cultures grown on TNA under selective conditions, 
as appropriate for 18 h at 37°C.  Bacterial suspensions were adjusted 
spectrophotometrically (A600= 0.08-0.1) and shaken at 170-200 rpm at 37 ºC.  Once 
cultures attained an OD600= 0.5, they were centrifuged at 7741 X g for 10 min at 4 ºC 
and the pellet was resuspended in 10 ml of 0.85% NaCl. Centrifugation was repeated 
and pellets were resuspended in 10 ml of 0.85% NaCl.  The 10 ml suspensions were then 
aliquoted to individual sterile petri plates and UV irradiated (400µw/cm2/sec) for 7 sec.  
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UV irradiated cells were transferred to  a 500 ml Erlenmeyer flask with 10 ml 2X TN 
broth and 30 ml TN broth and grown at 37 º C (180 rpm) with the OD600 sampled and 
recorded at 60 min intervals. 
  Tailocin activity quantification.  Deletion mutants, BC0425 ∆ bctN, BC0425 ∆ 
bctR, BC0425 ∆ recA and BC0425-WT were UV induced as described above.  
Suspensions were made in 20 ml TN broth from cultures grown on solid media under 
selective conditions, as appropriate for 18 h.  Bacterial suspensions were adjusted 
spectrophotometrically (A600= 0.08-0.1) and shaken at 170-200 rpm at 37 ºC.  Once 
cultures obtained an A600= 0.5, they were centrifuged (7741 X g) for 10 min at 4 ºC and 
the pellet was resuspended in 10 ml of 0.85% NaCl. Centrifugation was repeated and 
pellets were resuspended in 10 ml of 0.85% NaCl.  The 10 ml suspensions were then 
aliquoted to individual petri plates and UV irradiated (400µw/cm2/sec) for 7 sec.  UV 
irradiated cells were combined in a 500 ml flask with 10 ml 2X TN broth and 30 ml TN 
broth and incubated at 37 º C (200 rpm).  After 4 h, the cultures were centrifuged and the 
supernatant filter-sterilized. The supernatant was assayed for tailocin activity using the 
overlay spot assay and a plate assay. 
The overlay spot assay was used to assay for tailocin activity as described in 
Chapter II.   Serial dilutions (1:10) of preparations were spotted (10 µl) onto TNSA 
seeded with B. cenocepacia PC184, allowed to dry and incubated at 37°C. After 18h 
plates were accessed for zones of inhibition.  Zones of inhibition were indicative of 
tailocin activity.   
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 For the tailocin plate assay, colonies were short-streaked onto TNA contained in 
a glass petri plate and incubated at 37°C. After 18 h plates were exposed to chloroform 
vapor by adding 2 ml of chloroform to the lid of the plate and inverting the plate on top 
of the lid for 20 min and then ventilated for an additional 30 min to remove vapors.  The 
plates were then overlayed with TNSA, seeded with B. cenocepacia strain PC184, 
allowed to harden, and incubated at 37°C. After 18 h plates were evaluated for zones of 
inhibition.   
Transmission Electron Microscopy (TEM).  TEM was performed using high 
titer lysates, with 1011 tailocin/ml spotted onto 400 mesh carbon-coated copper grids and 
negatively stained with 2% (wt/vol) uranyl acetate. The samples were visualized with a 
JEOL 1200EX at an accelerated voltage of 100 kV. 
 
RESULTS 
 
Identification of transcriptional regulators.  Studies of PAO1 strains defective 
in the synthesis of R2, F2, and S2 pyocins, together with complementation tests, allowed 
two regulatory genes, prtN and prtR, to be identified upstream of the R2-F2 pyocin 
genes in PAO1 (75). Based on the genetic organization of R2-pyocins of P. aeruginosa, 
identification of potential transcriptional regulators was conducted by analyzing the 
Bcep0425 tailocin cluster for genes located upstream of the tailocin structural genes and 
those which were transcribed in the opposite direction.  Based on this criteria, two 
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putative genes, bctN and bctR, were identified and their homology to known repressors 
and transcriptional activators was determined (Fig. 4.1 A).   
The predicted bctN gene product was composed of 98 amino acid residues and 
did not exhibit any significant homology to any known protein sequences (Fig. 4.1 C).  
This was consistent with the identified prtN gene of P. aeruginosa strain PAO1.  The 
bctN showed homology to hypothetical proteins found in other Burkholderia strains 
(Fig. 4.1 C).  The predicted bctR gene product was composed of 163 amino acid residues 
and contained a helix-turn-helix DNA-binding domain, which is a characteristic of 
known repressors (2, 15, 76).  BctR showed significant homology to known 
transcriptional regulators found within Burkholderia and Pseudomonas strains, such as 
B. glumae (Bg), B. multivorans CGD1 (Bm) and P. fluorescens (Pf) (Fig. 4.1 B). 
Targeted mutagenesis of putative transcriptional regulators.  Using the 
allelic exchange system developed by Hamad et al. (41), deletion mutants were 
constructed of the putative regulatory genes, bctN and bctR, of BC0425.  The recA, 
which is necessary for pyocin production, was identified in the BC0425 sequence based 
on homology to B. cenocepacia J2315, and a deletion mutant of this gene was also 
constructed to determine its effect on tailocin production and lysis.   
BC0425-WT, BC0425 ∆ bctN, BC0425 ∆ bctR, and BC0425 ∆ recA were UV 
induced and their optical densities monitored to determine how each deletion would 
affect lysis.  Lysis of BC0425-WT coincides with a sudden drop in OD600 and release of 
tailocin to its surroundings, as determined by the overlay spot assay.   Lysis of ∆bctR 
and ∆bctN mutants was delayed by 60 min as compared to BC0425-WT (Fig. 4.2) with 
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Fig. 4.1.  Identification of Bcep0425 transcriptional regulators, bctN and bctR.  (A) 
Transcriptional direction of putative bctR and bctN relative to Bcep0425 structural 
proteins and lysis cassette.  Genes are not drawn to scale.  (B) Amino acid sequence 
alignment comparison of Bcep0425 (Bc*) BctR to transcriptional regulatory proteins.  
N-terminal amino acid sequence of BctR exhibits homology to N-terminal parts of a 
hypothetical phage protein of B. cenocepacia J2315 (Bc), a transcriptional regulator 
from the XRE family in B. glumae BGR1 (Bg), a helix-turn-helix domain protein in B. 
multivorans CGD1 (Bm) and a Cro/CI family transcriptional regulator protein in P. 
fluorescens (Pf).  (C) Amino acid sequence alignment comparison of Bcep0425 (Bc*) 
BctN to hypothetical proteins.   N-terminal amino acid sequence of PrtN exhibits 
homology to N-terminal parts of a hypothetical phage protein of B. cenocepacia J2315 
(Bc), a hypothetical protein of B. ubonensis Bu (Bu), and a hypothetical protein of B. 
oklahomensis (Bo).   
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Fig. 4.2.  Growth curve of BC0425 and bctR, bctN, and recA mutants post-UV 
induction.  Lysis of BC0425-WT coincides with a sudden drop in OD600.  The OD600 was 
sampled and recorded at 60 min intervals.  Results are representative of duplicate 
experiments.   
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lysis not observed until 3 h post-UV induction as compared to BC0425-WT, which 
occurred 2 h post-induction (Fig. 4.2).  Lysis for the ∆bctR and ∆bctN mutants was not 
expected, since both were hypothesized to be involved in tailocin induction and 
production. The observed lysis at 3 h post-UV induction for the ∆bctR and ∆bctN 
mutants is proposed to have occurred as a result of a temperate phage (designated 
Bcep315; no host identified to date) that was identified in UV induced lysates of strain 
BC0425 by electron microscopy (Fig.4.3).  Lysis was not observed for the BC0425 ∆ 
recA mutant (Fig. 4.2).  This was the same observation made for R-pyocins where the 
recA has been shown to be essential for both phage and pyocin production.   
Tailocin activity of bctR, bctN, and recA mutants.  Regulation of tailocin 
Bcep0425 was thought to be similar to that of the R2-type pyocins produced by PAO1.  
BC0425-wild type (WT), BC0425 ∆ bctN, BC0425 ∆ bctR, and BC0425 ∆ recA were 
UV induced and the lysates from cultures were assayed for tailocin activity using both 
the plate assay and overlay spot assay.  When detecting tailocin activity, the plate assay 
was found to be more sensitive than the overlay spot assay.  The supernatant of UV 
induced BC0425-WT exhibited tailocin activity of 1012 tailocins/ ml and the plate assay 
showed a small zone of inhibition, which indicates a positive score for tailocin activity 
(Table 4.3).  If Bcep0425 was regulated similarly to pyocins, then the deletion of the 
putative activator gene (brtN) should result in no tailocin production in UV induced 
cultures.  In Table 4.3, no tailocin activity was observed in BC0425 ∆ bctN lysates using 
either the plate assay or overlay spot assay.  This was expected since the PrtN was no 
longer able to activate the tailocin genes.  A similar result was observed with the induced  
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Fig. 4.3.  Electron micrograph of lysate from UV treated BC0425.  Tailocin Bcep0425 
can be observed along with temperate phage Bcep315 produced by BC0425.  The solid 
arrow and asterisk indicates phage Bcep315 and tailocin Bcep0425, respectively.  
Sample was stained with 2% (wt/vol) aqueous uranyl acetate.  Bar = 100 nm 
    
 
 
 
 
  
 
96
         Table 4.3.  Tailocin activity of bctR, bctN, and recA mutants 
 
      +/- indicates tailocin activity 
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culture of the BC0425 ∆ recA strain (Table 4.3).  Tailocin activity was also not observed 
using either of the plate assay or overlay spot assay.  The deletion of the putative 
repressor (brtR) should have resulted in constitutive tailocin production, since BctR is no 
longer repressing transcription of the bctN activator gene.  This was not observed in 
BC0425 ∆ bctR induced lysates.  No tailocin activity was detected using the overlay spot 
assay, but was detected using the more sensitive plate assay (Table 4.3).  These results 
indicate that the BctR may not only be acting as a repressor, but an activator of tailocin 
genes as well.     
Complementation of bctR, bctN, and recA mutants.  In trans complementation 
of BC0425 ∆bctR, BC0425 ∆ bctN and BC0425 ∆ recA deletion mutants was achieved 
using plasmids pMo168-bctR-comp, pMo168-bctN-comp and pMo168-recA-comp,  
respectively. BC0425-WT, BC0425 ∆ bctN-comp, BC0425 ∆ bctR-comp, and BC0425 
∆ recA-comp were UV induced and the lysates from cultures were assayed for tailocin 
activity using both the plate and overlay spot assays.  In trans complementation of 
individual mutants restored Bcep0425 tailocin activity to the BC0425 ∆ bctN, BC0425 ∆ 
bctR, and BC0425 ∆ recA mutants (Table 4.4).  
 
DISCUSSION 
 
The SOS regulatory system of E. coli is a set of responses to agents that threaten 
the cell by disrupting the structure or synthesis of its DNA (69, 115).   The SOS 
regulatory system is controlled by the action of the LexA repressor, which regulates a set  
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     Table 4.4.  Tailocin activity of bctR, bctN, and recA complements 
 
     +/- indicates tailocin activity 
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of ~20 genes during normal growth, and the RecA protein, which is required for 
inactivation of the LexA repressor after treatments that damage DNA (i.e. UV 
irradiation) (69, 115).  RecA is required for the autodigestion of the LexA repressor (67).  
LexA repressor is inactivated by specific cleavage of an Ala-Gly bond (44, 68, 70).  
Phage repressor inactivation is similarly mediated by cleavage at an Ala-Gly bond near 
the center of the polypeptide chain by activated RecA (23, 85).  The production of 
pyocins in P. aeruginosa is inducible by treatments that cause DNA damage and 
synthesis of pyocins is effectively dependent on the recA gene (93).  The LexA repressor 
does not seem to be involved in pyocin synthesis unlike the prtN activator gene and prtR 
repressor gene identified by Matsui et al. (75).  In this Chapter we provided evidence for 
the involvement of RecA and two putative transcriptional regulators, BctN and BctR, in 
the production of tailocin Bcep0425.   
The deletion of recA and bctN in BC0425 did not result in tailocin production, 
since each was expected to be required for the activation of tailocin Bcep0425 genes, 
based on observed results with pyocins R2 and F2 in P. aeruginosa PA01 (Table 4.3).   
Based on the regulation of pyocins in P. aeruginosa, the deletion of the putative 
repressor (brtR) should have resulted in constitutive tailocin production, since BctR is no 
longer repressing transcription of the bctN activator gene.  This was not observed for the 
BC0425 ∆ bctR mutant (Table 4.3).  In fact, we observed the opposite effect and 
minimal amounts of tailocin were detected.   
 There are three characteristic features of known repressor proteins involved in 
the SOS regulation of genes (i) The N-terminal sequence contains a helix-turn-helix 
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domain necessary for binding DNA (ii) The presence of an Ala-Gly (Cys-Gly in the Φ80 
cI repressor) to be cleaved by the activated RecA protein (28, 44, 94) and (iii) A Gly-
Asn-Ser-Met sequence that is conserved among phage and LexA repressors and 
proposed to be involved in the cleavage of these repressors (102).  The BctR contains 
two of the three characteristic features of known repressors.  The BctR contains a helix-
turn-helix domain and contains an Ala-Gly sequence at residue 76 (Fig. 4.1).  This 
provides evidence that BctR may be acting as a repressor.  
Repressors of transcription have been recognized as central to the regulation of 
gene expression in prokaryotes.  Their function was initially thought to be limited 
specifically to the turn-off of transcription. This view has changed since it became 
known that the λ repressor could serve as an activator and the cAMP receptor protein, a 
known activator, could serve as a repressor of transcription (73, 86, 106).  Our results 
indicate that the putative repressor, BctR, may not only be acting to repress bctN, but 
may be involved in the activation of tailocin genes as well.     
The results presented in this study were not consistent with the regulation model 
proposed for the pyocins of P. aeruginosa, where BctR acts to repress bctN, which in 
turn activates pyocin genes.  Future studies will focus on determining the exact role of 
recA, bctN and bctR in the induction process of tailocin Bcep0425 genes.   
 
 
 
 
  
 
101
CHAPTER V 
CONCLUSION 
 
 The Burkholderia cepacia complex (Bcc) comprises a group of Gram negative, 
phenotypically similar species (21, 109).  Bcc organisms are extremely diverse and 
versatile in their metabolic capabilities.  While Bcc bacteria can be involved in 
beneficial interactions with plants, they are also considered opportunistic pathogens in 
immunocompromised patients, specifically those with cystic fibrosis (9, 34, 63).  
Essentially all Bcc isolates demonstrate in vitro broad-spectrum antibiotic resistance.  In 
fact, many clinical isolates are resistant to all currently available antibiotics, rendering 
antibiotic therapy ineffective.  With the emergence of multi-drug resistant bacteria, the 
potential use of phage-tail-like high molecular weight bacteriocins, or "tailocins", as 
alternative anti-bacterial agents against bacterial infections is being reexamined.   
 In this study, we have identified a broad host range tailocin from B. cenoepacia 
strain BC0425, designated Bcep0425.   We have determined the genetic organization of 
the Bcep0425 tailocin cluster and have identified the major structural proteins and lysis 
cassette (Chapter II).  We have reported for the first time genes involved in replication 
and integration that are associated with a pyocin/tailocin gene cluster.  This provides 
evidence that tailocin Bcep0425 is a defective phage.  The identified gene products of 
the Bcep0425 tailocin cluster showed homology to Burkholderia phage KL3 (Chapter 
II).  Tailocin Bcep0425 and phage KL3 are also organized similarly, except Bcep0425 
does not contain genes involved in capsid formation or DNA modification.  The 
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significant homology and similar gene order between Bcep0425 and phage KL3 
provides evidence that Bcep0425 may be a derivative of phage KL3 or related P2-like 
phage.   The presence of a lysis gene cassette similar to those for bacteriophages is also 
supporting evidence that tailocin Bcep0425 is a defective phage (Chapter II).  The 
function of the Bcep0425 holin, along with the antiholin and endolysin, were confirmed 
using mutational analysis. Upon examination of the lysis cassette a new class of holin, 
which contains 4 TMDs with a N-in and C-in topology, was identified (Class IV). 
Tailocin Bcep0425 was shown to inhibit 70% of Burkholderia isolates tested and 
strains of Pseudomonas aeruginosa and Escherichia coli (Chapter III).  The Bcep0425 
receptor site was determined to be part of the outer core component of the bacterial LPS 
(Chapter III).  The testing of the sensitivity of genetically defined LPS mutants, of P. 
aeruginosa and B. cenocepacia, confirmed that L-rhamnose and α-glucose are the 
Bcep0425 receptor sites (Chapter III).    
In Chapter IV we provide evidence for the involvement of RecA and two novel 
transcriptional regulators, BctN and BctR, in the production of tailocin Bcep0425.  The 
results presented in Chapter IV were not consistent with the regulation model proposed 
for the pyocins of P. aeruginosa, where BctR acts to repress bctN, which in turn 
activates pyocin genes.    Our results indicated that the putative repressor, BctR, may not 
only be acting to repress bctN, but may also be involved in the activation of tailocin 
genes as well.  Future studies will focus on determining the exact role of recA, bctN and 
bctR in the induction process of tailocin Bcep0425 genes.   
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